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RNA REPLICATION BY POLIOVIRUS RNA-DEPENDENT RNA POLYMERASE: 
EFFECTS OF RESIDUE 5 ON ELONGATION COMPLEX STABILITY AND 
PROCESSIVITY  
 The poliovirus (PV) RNA-dependent RNA polymerase (RdRP) is a small, single-
subunit, enzyme that is responsible for the replication of the viral genome. PV genome 
replication is much more involved than just repetitively incorporating a single nucleotide 
into an oligonucleotide primer. The polymerase must first go through multiple steps of 
initiation before processive replication can happen. During primer-dependent initiation, 
the polymerase must bind the primer/template RNA substrate and undergo a 
conformational change to form a stable RNA-polymerase complex. After the stable 
RNA-polymerase complex is formed the polymerase undergoes a second conformational 
change associated with the addition of the first nucleotide to the primer. It is only after 
these few steps of initiation that the polymerase can begin processive elongation. The 
work presented in this dissertation addresses a structure-function relationship related to 
initiation and processivity of the PV RdRP. Specifically, my work shows that the PV 
RdRP residue 5 is involved in forming and maintaining the stable, elongation-competent 
complex. Also, the complex stability can be modulated by downstream RNA interactions 
or by the number of nucleotides that are incorporated to form the stable complex. Lastly, 
my data demonstrate evidence of an RNA rearrangement during elongation complex 
ii
formation and show that the maintenance of a stable elongation complex is required for 
processive RNA replication, which is required for virus replication. To end, these data 
elucidate a more complete understanding of the structure-function relationships of the 
viral RNA polymerase and could eventually facilitate in the design of specific 
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1.1 Poliovirus History: Discovery, Disease and Taxonomy 
1.1.1 Discovery 
 Poliovirus (PV) was first recorded as an infectious virus in 1908 by Landsteiner 
and Popper after the epidemic emergence of poliomyelitis, a human central nervous 
system disease that leads to paralysis (50, 86). Landsteiner and Popper demonstrated 
bacterially sterile transmission of the disease from human to rhesus monkeys by injection 
of spinal fluid from a symptomatic child into the peritoneum of the monkey. Although, 
this was the first scientific evidence of poliovirus as an infectious virus, the first record of 
poliomyelitis has been dated back as far as 1500-1333 B.C. to the early Egyptians (50). 
 Detailed studies of PV began around the early 1950s when Enders, Weller and 
Robbins first cultivated the virus in human tissue (51, 158). This work, along with the 
ongoing PV epidemic, pushed the scientific community to begin intensive research of the 
PV that eventually led to the development of two vaccines, the inactivated virus vaccine 
developed by Jonas Salk and the attenuated virus oral vaccine by Albert Sabin (50, 138). 
Since the development of the vaccine, PV research has led to many firsts in the field of 
virology, including the first infectious clone of an animal virus RNA genome (130) and 
the first high resolution three-dimensional image of a human virus (72); also, of particular 
importance to the research in this dissertation, studies by Baltimore et. al. provided the 
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first direct evidence of RNA replication in a human by the PV RNA-dependent RNA 
polymerase (RdRP) (18). 
1.1.2 Disease 
 Polioviruses are enteroviruses, generally meaning viruses that infect or can be 
found in the intestines and are spread in a fecal-oral transmission cycle. The poliovirus 
receptor, PVR or CD155, is only expressed in human cells and thus PV has no other 
vectors of transmission (98, 129). Since PV is spread through fecal-oral transmission, the 
virus initially infects and replicates in the gut of the host, which commonly leads to the 
virus entering the bloodstream. PV may invade the central nervous system where it can 
destroy motor neurons, causing muscular paralysis known as poliomyelitis (Fig. 1.1). The 
incubation period for poliomyelitis is about 10 days and occurs in 1 out of 150 PV 
infections (106, 107). In about 10% of PV infected individuals, a secondary illness occurs 
called abortive poliomyelitis. Abortive poliomyelitis can cause multiple non-specific 
infections such as upper respiratory tract infection, gastrointestinal illness, and influenza 
like infections (65, 83). In 25-50% of cases,  abortive poliomyelitis leads to what is now 
known as post-polio syndrome or PPS (40). PPS is caused by residual effects of 
poliovirus infection and causes axonal sprout degeneration but the actual cause of 
degeneration is unknown (Fig. 1.2)  (85). Symptoms include muscle weakness, pain and 
fatigue and usually occur 15-30 years after acute infection (34).  As the PV infected 
individuals age, PPS is becoming more of a medical concern and is currently an area of 
significant research. 
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FIG 1.1. Postulated model of PV pathogenesis.  PV enters the human host 
through fecal-oral transmission. Upon infection the virus replicates in the mucosal 
cells of the gastrointestinal tract where it commonly drains into the lymph nodes to 
reach the blood stream.. In a few cases the virus in the blood stream  is spread to 
extraneural tissues (fat and muscle cells) where more replication occurs, resulting 
in sustained vireama, ultimately increasing the chances of virus invasion of the 
spinal cord where the virus causes axonal degeneration causing paralytic 
poliomyelitis. Racaniello 2006 Virology. (129) 
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FIG 1.2. Postulated model of post-polio syndrome.  (A)  Healthy muscular 
motor neuron . The  cell body is located in the spinal cord (left) and muscle fibers 
(right) are penetrated by the  axon and axonal sprouts. (B) Infection of motor cells 
by PV causes neuron degeneration. (C) Axonal sprouting to make up for neurons 
lost by PV infection. (D)  Hypothesized axonal sprout degeneration induce by 
post-polio syndrome.  Lambert et al. 2005 Anesthesiology. (85) 
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1.1.3 Taxonomy 
 Poliovirus is a member of the Picornaviridae family of small (Pico-) non-
enveloped, icosahedral viruses that have a single-stranded positive-sense RNA genomes 
(142). The Picornaviridae includes several closely related and medically important 
viruses such as poliovirus, rhinovirus, hepatitis A virus, coxsackievirus and echovirus. 
These viruses cause a wide range of acute diseases in humans, including poliomyelitis, 
the common cold, liver disease, heart disease, and aseptic meningitis. Poliovirus is the 
best known and most studied member of the Picornaviridae family and is generally 
considered the prototypical picornavirus. 
Recently the International Committee in Taxonomy of Viruses (ICTV) has 
developed a new system of virus classification where viruses are grouped by order, 
family, genus and species. The PV now belongs to the new Picornavirales order that 
includes plant and animal viruses from five families including Picornaviridae family, 
genus Enterovirus, species human enterovirus C (155).  This virus classification system is 
an ongoing effort in which thousands of viruses still remain unclassified while new 
viruses are added each year. For example the Picornaviridae family included eight genera 
in 2008 and 12 genera in 2009, which is the most recent report to date. 
1.2 Poliovirus Eradication Efforts and Debate 
 In 1988 the World Health Organization (WHO) launched the first campaign for 
the eradication of poliovirus. Since that time the world has seen a 99% decrease in polio 
cases. However, there are a few areas of the world where PV remains endemic in the 
human population, including northern India, Nigeria and the border between Afghanistan 
and Pakistan (1). Poliovirus eradication seemed likely when first proposed as a vaccine 
5
had been developed, we had diagnostic techniques that were able to detect PV, and the 
virus was maintained completely in a human host, where spread would be relatively easy 
to control. The oral poliovirus vaccinations (OPV), designed by Albert Sabin in 1941, 
contain three attenuated strains of poliovirus that induce strong immunity against 
infection (50, 138). The human immune response is generally able to recognize and 
destroy the attenuated virus before it causes significant disease. However, in the short 
time that the virus is replicating (~2 weeks) in the vaccinated host, some of the attenuated 
vaccine strains have been observed to revert back to wild-type poliovirus and are shed as 
virulent virus (49). If a percentage of the population is not immunized, the newly shed 
virulent virus may cause an outbreak of poliomyelitis among non-immune individuals, 
thus remaining a significant threat in some areas of the world. The inactivated virus 
vaccine (IPV) used in the developed world circumvents this problem, but it is too 
expensive for the global eradication campaign (105). Thus, there is a strong argument for 
the development of antivirals or better vaccines.  
1.3 Poliovirus “Life-Cycle” 
 The PV “life-cycle” has been studied extensively since its discovery in the early 
1900s. However, it wasn’t until the development of cell biology techniques that 
molecular details of viral replication could be better illuminated. The term “life-cycle” is 
commonly used among virologists to explain virus replication and propagation but is not 
necessarily scientifically correct, since a living organism is defined by the capacity for 
metabolism, growth, reproduction and reaction to stimuli. Most viruses fulfill all of these 
requirements except for the ability metabolize, and no viruses have this capability. 
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Regardless, here PV replication and propagation will be referred to as the virus “life-
cycle” to be in agreement with the literature. 
1.3.1 Replication in the human 
 Oral ingestion is the most common mechanism of PV infection (Fig. 1.1). The 
ingested virus replicates in the oropharyngeal and intestinal mucosa of the human host 
(137). After multiplication in the mucosa, the virus drains into the lymph nodes and 
eventually into the bloodstream, causing mild infection symptoms such as headache and 
fever; in 99% of PV infected individuals this is the extent of the disease (107). However, 
in 1% of infected individuals viral replication begins to occur at non-neural tissues such 
as adipose and muscle cells in the body, increasing viremia and resulting in viral entry 
into the central nervous system. In these cases the virus replicates in and destroys motor 
neurons within the spinal cord, brain stem and motor cortex, leading to muscular 
paralysis (129).  
 As previously mentioned, humans are the only known natural hosts of poliovirus, 
being the only animal expressing the poliovirus receptor, CD155. It has been shown that 
some monkeys can be experimentally infected and cultured mouse cells are permissive, 
meaning the cells will generate infectious virus upon transfection, but infection cannot be 
spread  (80). To show that mice were not susceptible PV infection due to the fact that 
they did not have the CD155 receptor, transgenic mice were generated expressing the 
human cellular receptor CD155 and these mice became permissive to infection through 
injection, but were still not susceptible through oral transmission (80). The biological 
function of CD155 (commonly referred to in the literature as the poliovirus receptor, 
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PVR) was unknown from its discovery in 1989 until 2003 when CD155 was finally 
established as a cell-cell adhesion molecule (101).  
 It was originally hypothesized that tissue tropism of the PV was localized to 
specific cells and tissues determined by expression of CD155 (137); interestingly this is 
not the case, rather tissue tropism is dependent upon cellular differences in cap-
independent translation of the PV RNA genome, mediated by an internal ribosome entry 
site (IRES) (63, 93). For example, it has been shown that poly(A) and poly(C) binding 
protein (PABP and PCBP2) variants have the ability to bind the PV genome to mediate 
translation (68).  
1.3.2 Replication in the cell 
 There are five required events associated with PV infection of the host cell: entry, 
viral genome translation, viral genome replication, virion assembly, and virus exit (Fig 
1.3) (44), and the loss of any one of these steps would be detrimental to viral propagation. 
The PV virion is a small, non-enveloped, icosahedral protein coat containing 60 copies of 
each viral protein (VP), VP1, VP2, VP3 and VP4 (72). The virion contains a single strand 
of positive-sense RNA, shown in Fig. 1.4,  that is covalently linked to viral protein VPg 
on its 5’ end (55, 111, 161). Upon infection, VPg is cleaved from the RNA and the 
positive-sense genomic RNA is translated by host translation machinery to produce a 
~250 kD viral polyprotein (5). Translation of viral RNA is initiated by a cap-independent 
mechanism involving a segment of RNA located in the 5’ non-translated region including 
the IRES. The viral polyprotein is processed co- and post-translationally by virally 
encoded proteases to form multiple mature viral proteins required for replication of the 
RNA genome and synthesis of virions (2).  
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FIG 1.3. Poliovirus “life-cycle” overview.  The PV “life-cycle” can be broken 
down into five main steps. 1, viral entry, including receptor binding, endocytosis 
and RNA release. 2, cap-independent translation of the viral genome. 3, formation 
of viral replication complexes for RNA replication by 3Dpol. 4, virion assembly 
and genome encapsidation and 5, viral exit via cell lysis. Adapted from De Jesus. 


















FIG 1.4 Poliovirus positive-strand RNA genome.. The 5’end is VPg linked. The 
5’ NTP includes the cloverleaf and IRES (internal ribosome entry site). The 
polyprotein open reading frame consists of viral proteins P1, P2, and P3. P1 
proteins make up the structural capsid proteins. The P2 and P3 proteins include all 
non-structural proteins involved in formation of replication complexes and RNA 
replication. In red is the RNA-dependent RNA polymerase 3Dpol. After the 
polyprotein is the 3’ NTR followed by a poly(A) tail. Adapted from  Xiang  et al. 
1998. J. Virol. (161). 
        
          








 Entry:  Like all viruses, the PV is inert outside of the host cell, having no 
metabolic processes allowing for multiplication; therefore, it is essential for the virus to 
enter its host to maintain its existence. Inside the host, the PV commandeers host cell 
machinery required for its replication thus the virus will evolve and multiply, an essential 
part of virus “life cycle”. As previously mentioned, for PV to enter a host cell that cell 
must be expressing the CD155 receptor. Once the PV – CD155 complex is formed it 
undergoes endocytosis by the host (Fig. 1.5) (29). After endocytosis there is a 
conformational change in the capsid structure that results in release of the viral RNA into 
the host cell cytoplasm  (88). The 5’ VPg (a protein required for priming RNA 
replication) is then cleaved from the viral RNA genome by an unknown host cell enzyme 
and the genome is ready for translation (5, 111). 
Translation:  PV translation occurs in a cap independent manner facilitated by the 
presence of an internal ribosome entry site (IRES) (120, 121). The IRES is a highly 
structured RNA element that can be bound by host translational machinery to initiate 
translation of the PV genome. The PV genome is translated from a single open reading 
frame resulting in a large polyprotein. This polyprotein is cleaved co- and post-
translationally in cis and in trans by viral proteases 2Apro and 3CDpro. The large 
polyprotein is divided into three main groups; P1, P2, and P3. The P1 proteins (VP1, 
VP2, VP3 and VP4) are structural proteins involved in forming the virus particle (77), the 
P2 proteins (2A, 2B and 2C) are involved in membrane rearrangement and the processing 
of other proteins both viral and host, and the P3 viral proteins (3A, 3B [VPg], 3C and 3D) 
are involved in viral RNA replication. Polyprotein processing also results in intermediate 
products (2BC, 3AB, and 3CD) that serve functional purposes in viral reproduction (77) 
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FIG 1.5 Poliovirus host cell entry. The 160S virus particle (dark blue) binds PV 
receptor, CD155, and undergoes a conformational change to form the 135S 
particle, which is internalized by an actin and tyrosine kinase-dependent 
mechanism. Viral RNA is released from the 135S particle 100-200 nm into the 
host cell and the empty capsid is transported further into the cell via microtubules.  
Brandenburg et al. 2007. PLoS biology. (29) 
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(also reviewed in (160)). After translation of the first few viral 2Apro molecules, the virus 
is able to take over most of the host translation machinery by cleaving eIF4G host 
translation protein in such a way that the translation machinery is still functional for virus 
translation but insufficient for host mRNA translation (52, 139); thus, rendering the host 
incapable of synthesizing cellular proteins and allowing viral protein production to 
increase significantly.   
RNA Replication:  RNA replication occurs in large membrane-bound replication 
complexes, illustrated in Figure 1.6,  that contain P2 and P3 viral proteins and host 
proteins such as poly(A) and poly(C) binding proteins (70, 103). Within poliovirus 
replication complexes, positive-sense RNA is circularized through a protein-protein 
bridge (70). In these replication complexes asymmetrical genome replication takes place 
by the virally encoded RNA-dependent RNA polymerase, 3Dpol, by first making a 
negative-strand copy of the genomic RNA, which in turn serves as a template for the 
generation of multiple copies of nascent positive-strands (Fig. 1.7) (21). New positive 
strand RNAs are either translated to make additional protein for virion production, 
replicated to increase the amount of negative strand RNAs, or packaged into virion and 
released from the cell. When the genomic RNA is isolated from replication complex the 
negative-strand that is complementary to the positive-strand remains in a duplex, known 
as replicative form (RF) (17, 21). Upon initiation of positive strand RNA synthesis, the 
duplex RNA is melted and from this point forward the negative strand RNA exists as a 
replicative intermediate (RI) where multiple positive strands of RNA are being 
synthesized from a single template. Unlike negative strand synthesis, the positive strands 
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FIG 1.6 Model of the poliovirus replication complex. Cartoon representation of 
negative-strand synthesis by 3Dpol. PV RNA replication occurs in large ER 
membrane associated complexes. Viral P2 proteins, 2CATPase and 2BC, sequester 
host cell membrane and P3 proteins (3A, 3B [VPg], 3CD and 3Dpol) are 
responsible for RNA replication. The cre (cis-acting replication element) is 
required for VPg, primer, uridylylation and RNA replication. Host proteins are not 
shown. Adapted from Murray and Barton,.2003. J. Virol. (103) 
cre 
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FIG 1.7 Asymmetrical RNA replication. (1) Initiation of negative-strand RNA 
synthesis from the positive-strand genome. (2) Formation of replicative  form (RF)  
dsRNA. (3) Positive-strand initiation from the negative-strand RNA template. (4) 
Replicative form (RI) RNA, initiation of multiple positive-strands from a single 
negative-strand RNA. Time represents RNA replication in HeLa cytoplasmic 
extracts. Black circle represents RdRP, 3Dpol. Adapted from Barton and Flanegan. 




of RNA do not remain in duplex with their template, but rather are believed to be melted 
by the next replicating polymerase (Fig 1.7, RI) (28) .  
RNA replication is initiated by a di-uridylylation of viral protein, 3B (VPg). VPg 
di-uridylylation is templated by a stem-loop RNA structure located at nucleotides 4444-
4504 of  the PV genome called the cis-acting replication element (cre) (117). The loop of 
the cre provides a template adenosine (A5) base for uridylylation of the Tyr 3 hydroxyl 
(VPgpUpUOH) by 3Dpol. The process of uridylylation requires VPg binding to 3Dpol 
followed by the binding of this 3Dpol-VPg complex to the RNA cre (133). In the current 
model, VPg is first uridylylated by ester bond formation between α-phosphate of a UTP 
and the Tyr3 OH, this reaction is catalyzed by the 3Dpol with the cre A5 as the template. 
A singly uridylylated VPg (VPgpUOH) then slides back to base pair with A6 of the cre 
loop so that A5 is used once again as the template for incorporation of the second  uridine 
(119). Interestingly, since cre is essential for initiation of replication, they ensure that 
replication complexes are composed of viral RNA and not host mRNA (116). 
Encapsidation:  After multiple rounds of RNA replication, positive-strand 
genomic RNA is packaged into virus particles. Very little is understood about the 
encapsidation process, however, it is known to be closely coupled to RNA replication so 
that only RNA genomes that are being replicated are packaged (113). Some early work 
showed evidence of VPg acting as a packaging signal (111) but new evidence suggests 
that there may be more than just a single protein responsible for the coordination of RNA 
replication and packaging. One recent study suggests viral protein 3AB or 3CD permits 
transit of RNA from replication complexes to virus capsid particles (114).  Another 
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recent study suggests that viral protein 2CATPase is responsible for specificity of viral 
RNA encapsidation as it threads the viral RNA into the mature virus capsid particle (90).  
1.3.3 Replication in the cell-free HeLa extract system 
 The cell-free system uses HeLa cell cytoplasmic extracts to reconstitute authentic 
viral replication, a technique that has been used to study poliovirus replication 
successfully for many years (20, 48, 100). The cell-free coupled translation-replication 
system allows formation of pre-initiation RNA replication complexes (PIRCs) where 
synchronous RNA replication occurs. These complexes have been shown to be nearly 
identical to replication complexes in the host cell and therefore are considered authentic 
replication complexes (23). Addition of viral RNA to cellular extracts initiates the 
translation of RNA by host translation proteins. Like in vivo viral RNA replication, RNA 
replication in the cell-free system is synthesized asymmetrically when infected with the 
positive strand genome (23, 103). Adding 2 mM guanidine HCl cell-free replication 
prevents viral RNA replication while the RNA is translated; this permits the formation of 
membrane associated replication complexes. At low concentrations, guanidine HCl 
restricts the ATPase function of viral protein 2C which inhibits initiation of negative 
strand synthesis while having no effects on other viral or host proteins (21). Using this 
system, viral protein synthesis and RNA replication can be measured by pulse-labeling 
with 35S-Met and 32P-NTP incorporation, respectively. Upon removal of guanidine HCl, 
negative strand RNA replication is synchronously initiated. These replication reactions 
can then be quenched at various time points, making it possible to visualize initiation, 
elongation and termination of RNA on an agarose gel (21). Such aspects have proven 
extremely beneficial for RNA replication rate studies and examining various aspects of 
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positive and negative strand synthesis (21, 25). Conveniently, using this system, viral or 
host proteins can be added in trans and drugs that inhibit translation or replication can be 
added and then can be removed by centrifuging replication complexes and aspiration of 
the supernatant. Another advantage to using the cell-free system is that many studies can 
be completed without generating fully infectious virus by deletion of the P1 proteins from 
the genome, as capsid proteins are not required for the replication of the genome. 
 While this in vitro system recapitulates the steps required for PV replication, it 
may omit certain aspects of virus-host interactions. For example, cellular responses to 
viral infections that may affect viral replication, such as cell signaling and apoptosis (3), 
would remain undetected or deficient in this system. Also, PV replication occurs on 
virally sequestered ER membranes in the cell (27), certainly ER membranes constitute 
some of the membrane population in the cell-free system but the ER is not intact and it is 
likely that replication complexes are generated on any available membrane. Despite these 
potential pitfalls, the cell-free replication system offers an excellent system to gather 
insights to PV replication that are unattainable in the cell. 
1.3.4 Replication in classical biochemical systems 
 As well as the cell-free replication system, classical biochemical systems are also 
used as an in vitro system for studying PV replication. This system requires the minimal 
amount of materials needed for RNA replication. For PV replication the components 
include RNA-dependent RNA polymerase, 3Dpol, RNA template, primer (can be 
RNA/DNA oligomer or VPg), NTPs and Mg++ (118). Replication rates and efficiency 
depend greatly on reaction conditions such as pH, temperature and salt concentration (59, 
71). Using such systems, detailed kinetic mechanisms and structural insights into RNA 
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replication by 3Dpol have been determined (9, 13, 152). The ability to have stringent 
control of the system can be advantageous over other systems like the cell-free system 
where various undetected interactions can be occurring with host proteins, making the 
system unfit for such kinetic details. That being said, replication in these reconstituted 
systems do not represent authentic replication complexes and lessons gleaned from these 
assays often require recapitulation in in cell-free and/or cellular assays (71, 81).  
1.4 Poliovirus RNA Replication 
 In the early 1960s David Baltimore and colleagues discovered the enzyme 
responsible for the replication of the PV genome was an RNA-dependent RNA 
polymerase (RdRP) contained within the “D” protein from the P3 region of the 
polyprotein, commonly called 3Dpol (16, 18). The discovery that the PV polymerase was 
an RdRP came on the coattails of the discovery of the first RdRP in Mengovirus (131). In 
that study, the investigators showed that RNA could be synthesized in the presence of 
actinomycin D, a DNA-dependent RNA polymerase inhibitor (131). Soon after this 
discovery similar experiments were done for the PV to show that the PV also employed 
an RdRP for replication of the genome (18).  
 3Dpol synthesizes both positive- and negative-strand RNAs, which can be found in 
three different conformations: single-stranded positive-sense RNA, double-stranded RNA 
where positive- and negative- strands are base paired called replicative form (RF) , and 
replicative intermediate (RI) where multiple positive-strands are being synthesized from a 
single negative-strand template (17, 19, 41).  
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1.4.1 Negative-strand RNA synthesis 
 Negative-strand synthesis differs from positive-strand synthesis mainly in 
initiation. Negative-strand initiation requires that translation of the viral RNA be shut off 
to avoid ribosome, 5’3’, polymerase, 3’5’, collisions. Translation is shut-off by 3CD 
binding to the 5’ cloverleaf RNA structure, blocking binding of host translational 
machinery, specifically eIF4G (56).  Translation shut-off is not a problem for synthesis of 
positive-strand RNA because the negative-strand template is not translated. After 
translation shut-off, negative-strand synthesis is initiated by circularization of the PV 
genome through a RNA- protein-protein-RNA bridge that brings the 5’ and 3’ ends of the 
genome together (70). In this model host Poly r(A) Binding Protein (PABP) is bound to 
the 3’poly(A) of the viral RNA and Poly r(C) Binding Protein (PCBP2)  is bound to the  
5’ cloverleaf, along with viral protein 3CD (Fig.1.8) (156). The PABP-PCBP interaction 
is thought to bring 3CD in proximity to the 3’ end of the genome so that when 3CD is 
proteolytically processed 3Dpol can bind VPg or VPgpUpUOH and negative-strand 
synthesis can occur (61, 70).    
 Along with translation shut off and genome circularization, negative-strand 
synthesis also requires the ATPase activity of viral protein 2CATPase for initiation but not 
for subsequent replication (21, 95). This was discovered by GuHCl inhibition studies, 
where low mM concentrations of GuHCl were shown to inhibit negative-strand RNA 
initiation and upon removal of GuHCl negative-strand synthesis begins synchronously 
(21). Sequence analysis of GuHCl resistant virus populations indicated a N179G 
mutation in the predicted ATPase domain of 2C (15, 125). Later it was shown that these 
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FIG 1.8. PV genome circularization, negative-strand synthesis. (1) Binding of 
positive-strand RNA 5’ cloverleaf by host protein PCBP and viral protein 3CD. (2) 
Circularization of the RNA through PABP and PCBP protein interactions. (3)  
Cleavage of 3CD to 3C and 3Dpol for initiation of negative-strand RNA synthesis. 







mutations did inhibit ATPase activity of 2C (124), however, the role of 2CATPase in 
negative-strand initiation is still unknown.  
1.4.2 Positive-strand RNA synthesis 
 Unlike negative-strand synthesis, positive-stand synthesis absolutely requires 
priming from a uridylylated VPg (103). As discussed previously, VPg uridylylation 
occurs by 3Dpol transferase activity, templated by the RNA cis-acting replication element 
(cre). Significantly less is known about the molecular details of positive strand 
replication than negative-strand replication. For example, it is not well understood how 
VPgpUpUOH anneals to the 3’ end of the negative strand genome (143), nor is it known 
how the asymmetry of positive: negative-strand replication  is regulated (112).  
1.4.3 PV polymerase fidelity 
 An interesting characteristic of many viral RdRPs is that they generally have 
relatively low fidelity, meaning that they have a greater frequency of misincorporated 
nucleotides compared to DNA polymerases. Low fidelity has largely been attributed to 
the fact that RdRPs do not have 3'-exonucleolytic activity, which provides proofreading 
capabilities in DNA polymerases. Otherwise the core polymerase fidelity is quite 
comparable (12, 157). The poliovirus 3Dpol mutation rate (~10-4 misincorporations per 
nucleotide copied) is a very high mutation rate when compared to a DNA-dependent 
polymerase with exonuclease activity (10-9 misincorporations per nucleotide copied) (47). 
This low fidelity enables the virus to rapidly form subpopulations, or quasispecies, that 
differ from the parental virus by one or more nucleotides. The generation of quasispecies 
is thought to be a mechanism by which RNA viruses can evade selective environmental 
pressures, such as antiviral drugs and host immune response, and facilitate the spread of 
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the virus from one tissue type to another (46).  However, there is a limit to how much the 
viral genome can vary before propagation is affected. If the virus goes past this limit the 
population will no longer be able to propagate, an event referred to as “error catastrophe” 
(38). For example, poliovirus polymerase inserts about one wrong base for every 3800 
bases replicated about two misincorporations per genome (153, 154). If this frequency 
increases to three misincorporations per 3500 bases replicated, the virus may no longer be 
able to propagate (47). Current antiviral efforts have focused largely on bringing about 
modifications to the polymerase fidelity that either decrease polymerase fidelity to push 
the virus towards error catastrophe or increasing polymerase fidelity to reduce viral 
adaptability (154).  
1.5 Mechanisms of RNA Replication by 3Dpol 
 Although viral replication in vivo occurs in large replication complexes, primer 
dependent polymerization of RNA by purified poliovirus polymerase (3Dpol) can occur in 
solution in the absence of all other viral proteins. Most mechanistic details concerning 
poliovirus RNA replication have been determined in this manner, using purified 
polymerase and a symmetrical primer/template substrate (sym/sub) RNA complex (10, 
12, 30). More recently, the Peersen laboratory has employed a self-priming hairpin RNA, 
called Primer Elongation Template Element or PETE, to determine kinetic details of PV 
3Dpol function (59, 71, 99). The advantage of using PETE is that the primer and template 
are a single molecule that can prime from only a single site, as opposed to the self-
annealing sym/sub complex where there are two 3’OH that can serve as a primer. Also, 
the PETE RNA molecules are easily modified for fluorescent detection, convenient for 
high throughput and kinetic assays (59, 99). 
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1.5.1 Kinetic mechanism of initiation 
 In order to determine kinetic details of nucleotide incorporation, it was first 
necessary to be able to assemble a stable, active, elongation complex (EC). The EC is 
composed of 3Dpol, RNA substrate and the first NTP. The assembly of the stable EC, or 
initiation, is a two-step process that is separate from elongation (Fig. 1.9). In the first step 
3Dpol binds the RNA primer/template substrate, this has a slow rate of 0.1 µM-1 s-1 in no 
monovalent salt and 5 mM MgCl2 and 60 µM ZnCl2 and a dissociation rate of  0.1 s-1, 
determined using kinetic simulations (9). The dissociation constant of the polymerase-
RNA complex is dependent upon experimental conditions and the structure of the RNA 
substrate, but is generally reported to be in the low µM range (9, 99). The addition of the 
first nucleotide in initiation is ~2-3 orders of magnitude slower than the addition of 
sequential nucleotides in elongation (0.0001 s-1 vs. 0.06 s-1), but increases the EC stability 
~4 fold (7, 9, 71). This suggests that there is a conformational change in the polymerase 
involved with the formation of the EC, but such a change remains to be seen, even after 
the crystal structure of the PV 3Dpol EC was solved (60).  
1.5.2 Kinetic mechanism of elongation 
 Using the sym/sub assay, the complete kinetic mechanism for single nucleotide 
incorporation by 3Dpol has been determined (11, 13). The incorporation of a single 
nucleotide is a complex process involving multiple functions of a single polymerase. 
Kinetic studies of all known classes of polymerase indicate that they share a five step 
mechanism for the addition of a single nucleotide: 1) nucleotide triphosphate binding, 2) 
a conformational change, 3) phosphodiester bond formation, 4) a second conformational 
change and 5) pyrophosphate release (Fig. 1.9). Two steps in the mechanisms are 
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FIG 1.9. Kinetic mechanisms for RNA replication by 3Dpol. The kinetic 
mechanism for initiation (top) is a three step mechanism. After enzyme (E) and 
RNA (R) binding (k1) an E conformational change takes place (k2) followed by the 
slow incorporation of the first NTP  to form a very stable elongation –competent 
complex. The kinetic mechanism for elongation (bottom) occurs after initiation, 
and is a five step mechanism, each step is represented by blue arrows and the 













open closed closed open stable EC 
a indicates possible step for RNA translocation or where an extra step may be required 
for translocation. 
* indicates the conformational change associated with active site closure 
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believed to be rate limiting, assuming there are sufficient quantities of nucleotides 
available:  the first conformational change (step 2) and phosphodiester bond formation 
(step 3). It has been shown that small alterations in the first conformational change 
required for phosphodiester bond formation could significantly affect the ability of the 
polymerase to determine correct base pairing, which would have a large effect on fidelity 
(14). Fidelity of incorporation is largely based on the ability of the polymerase to 
determine whether the bound nucleotide is correctly paired to its complementary 
nucleotide on the template strand prior to catalysis (steps 2 and 3). If an NTP does not 
correctly pair with its complementary base, it is released from the polymerase active site 
before phosphodiester bond formation.  
1.5.3 Mechanism of termination 
 To date, there is no known mechanism of elongation termination other than the 
3Dpol falling of the 5’ end of the template or spontaneous dissociation during elongation. 
However, in vivo 3Dpol is able to generate abortive products suggesting that there may be 
some mechanism for termination. It has been found that the bacteriophage φ6 RdRP has 
terminal nucleotidyltransferase activity that aids in RNA replication termination (127). 
Such transferase activity has also been discovered in the PV 3Dpol but has not been 
directly linked to RNA replication termination (108). 
1.6 Poliovirus 3Dpol Structure 
 The first RdRP crystal structure, published in 1997, was of the PV 3Dpol (67). 
This structure was important to the field because it showed that RdRPs had the same 
overall right-hand conformation as other DNA-dependent DNA and RNA polymerases 
(DdDP and DdRP) (79, 140) . However, this structure was incomplete due to the entire 
26
“fingers” domain being disordered (residues: 1-12, 38-66, 98-181 and 270-290); 
therefore, many structural details of this domain remained elusive. The disordered 
regions of the polymerase were likely due to the crystal packing conformation resulting 
from the oligomerization of the polymerase on two interfaces, I and II (67). Interface I 
has a head-to-tail orientation where the thumb domain of one polymerase interacts with 
palm domain of another. Via this head-to-tail orientation it is possible that long fibers of 
polymerase could form. Before the crystallization of PV 3Dpol there were reports of the 
polymerase acting as an oligomer, as polymerization was found to be concentration 
dependent and displayed cooperative binding to RNA; also, chemical cross-linking after 
initiation indicated a direct protein-protein interaction that was pH dependent (115). Later 
it was shown by electron microscopy that mutations in residues of Interface I disrupted 
polymerase oligomerization (94). Interface II is between the thumb domain of one 
polymerase and the N-terminus of the next and suggested that two polymerase molecules 
interacted in trans to form the active polymerase. However, since this report there has 
been no data supporting the interaction of Interface II (152). 
 In 2004 the crystal structure of the complete Mahoney type 1 PV polymerase was 
determined by Thompson and Peersen (Fig. 1.10) (152). By interruption of Interface I, 
via L446D/R455D mutation in the thumb domain, the polymerase was stable in a 
different crystal packing conformation where all residues had good density.  The overall 
structure of poliovirus 3Dpol is similar to other viral RdRPs and conforms to the canonical 
right hand analogy where the active site palm domain is enclosed by the fingers and 
thumb domains. The fingers domain can be broken down into four separate amino acid 
stretches referred to as the index (residues 1-69), middle (residues 269-285), ring 
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FIG 1.10. Crystal structure of the complete PV 3Dpol. Top view of “right hand”. 
Palm domain in grey, magenta loop indicates the catalytic site. Thumb domain in 
blue. Fingers domain in green, orange, yellow and pink represent index, middle, 
ring and pinky fingers respectivly. Blue ball of index finger represents the N-







(residues 150-179) and pinky (residues 96-149 and 180-190) fingers. This allowed for 
clear description of amino acid, RNA and NTP interactions, also these regions are 
conserved in other picornavirus RdRPs (32). Of functional importance, this structure 
elucidated the structural basis for N-terminal burial required for polymerase activation 
(152).  As seen with the partial structure, functionally required regions of the polymerase 
are highly conserved among all the RdRPs in the Picornaviridae family. For example, 
regions involved in NTP binding and catalysis are nearly identical in structure and 
sequence, suggesting that changes to the structures or sequence of these domains could 
result in noticeable alterations in polymerase activity.  
 Recently the crystal structure of the active PV 3Dpol-RNA elongation complex 
was solved by Gong and Peersen (60). This is the first crystal structure of an active RdRP 
that has undergone multiple rounds of nucleotide incorporation. The structure has a 
significant amount of up- and downstream RNA, and shows evidence of active site 
closure upon NTP binding (Fig. 1.11) (60). This structure was solved by the formation of 
a very stable EC by the incorporation of four nucleotides on a PETE RNA substrate that 
has both upstream and downstream duplexes. The overall structure shows that the 
polymerase forms a clamp, composed of the 3Dpol pinky and thumb, around the upstream 
duplex RNA and suggests that dsRNA separation takes place as the template enters the 
polymerase active site by the index finger (Fig. 1.11). The structure shows that template 
nucleotides +1, +2 and +3 are single stranded, threading through the active site.  The +1 
nucleotide is base stacked against the upstream -1 nucleotide and poised for base paring 
with the incoming nucleotide. The +2 nucleotide is completely un-stacked from +1 and 
+3 nucleotides by a pocket within the index finger and Pro20, respectively. The +3 
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FIG 1.11. Crystal structure of the PV 3Dpol-RNA elongation complex. 
Template RNA strand is in cyan, downstream non-template strand in magenta and 
upstream  non-template is in bright green. Template nucleotides +1, +2 and +3 are  
colored orange, purple and cyan, respectively. The polymerase palm domain is 
colored in grey, thumb in blue. The index, middle, ring and pinky fingers are in 
green, orange, yellow and pink, respectively. Gong and Peersen .2010. PNAS. 
PDB code, 3OL6 (60) 
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nucleotide is newly separated from its complementary strand by 3Dpol residues 18 and 19 
in the index finger.  By the addition of cognate CTP and CTP analogues, a series of 
structures were produced showing various aspects of the catalytic cycle. Different from 
other DdDPs and DdRPs, it was found that active site closure in PV 3Dpol RdRP is 
generated from movements in the palm domain, rather than the fingers commonly seen 
with other polymerases. Importantly, this report also suggested that 3Dpol requires a sixth 
step in the kinetic mechanism of nucleotid  incorporation wherein translocation occurs. 
Although no structural evidence was seen for translocation, the absence of the 
translocation associated with any other steps and comparisons with other DNA and RNA 
polymerase structures, suggests that a conformational change associated with 
translocation could require a novel sixth step in the kinetic mechanism. In all, the 
determination of the PV 3Dpol and EC has been greatly beneficial in understanding the 
structure function relationships of all RdRPs and to the generation of this dissertation.  
1.7 Structure-Function Relationships of PV 3Dpol 
  The essential role of the RdRP in viral propagation makes it an important enzyme 
for understanding viral replication. Positive-strand virus RdRPs are highly homologous in 
structure and unique to viruses and some plants, making them a possible target for small 
molecule inhibitors. Currently the only antiviral against RNA viruses is a broad-spectrum 
nucleotide analogue, ribavirin, used to aid in treatment of hepatitis C but is not effective 
against all RNA viruses like the poliovirus (62). Therefore, there is a significant need for 
better antiviral therapeutics that more specifically target structural or functional aspects 
of the RdRPs. Even though the kinetic mechanisms for PV 3Dpol initiation and elongation 
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are known (9, 11, 13), and the complete structure and EC have been solved  (60, 152), 
our present understanding of the structure-function relationships is still incomplete. 
1.7.1 Replication fidelity 
 Investigation of antiviral resistance in the poliovirus polymerase revealed a 
Gly64Ser mutation in 3Dpol that produced a virus that is resistant to the mutagenic 
nucleotide analog ribavirin (39).  This mutation promoted ribavirin resistance by 
producing a slower replicating virus with a higher fidelity RdRP (123). It was later found 
that the slower replication rate of Gly64Ser 3Dpol could be attributed to a 3-fold decrease 
in the first conformational change (step 2) of the kinetic mechanism (14). Structural 
analysis concluded that the Gly64Ser mutation caused an increase in stabilization in the 
polymerase through hydrogen bonding interactions at the amino terminus that in turn 
caused a prolonged stabilization in a “fidelity check point” which resulted in increased 
fidelity (14).  
1.8 Scope of this Dissertation 
 This dissertation uses in vitro RNA replication systems, cell-free systems and 
infectious virus replication to elucidate structure-function relationships in the poliovirus 
(PV) RNA-dependent RNA polymerase. The first report (Chapter 3) investigates the 
functional role of residue 5 in RNA binding, elongation complex (EC) formation, 
elongation rate and EC stability. I initially hypothesized that residue 5 was involved in 
NTP incorporation but found instead it had a significant effect on EC stability. In Chapter 
4, I describe the investigation of the significance of EC stability for viral replication. I 
showed that the most significant effect can be seen in the processivity of elongation, 
where less stable ECs result in less processive polymerization. The data suggested 
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evidence of a downstream RNA interaction, which I further investigated in Chapter 5. In 
Chapter 5, I show data that support the hypothesis that PV 3Dpol does interact with single- 
and double-stranded downstream RNA and that a downstream duplex has significant 
effects on EC stability. However, it remains unclear as to whether residue 5 is directly 
involved in RNA interactions. Finally, in Chapter 6 I describe the impact of my 







Materials and Methods 
2.1 Plasmids and Viral cDNA 
2.1.1 pET26UbDH 
 pET26UbDH was kindly provided by Craig E. Cameron (Penn State University). 
pET26UbDH contains the open reading frame of the complete poliovirus (PV) 3Dpol from 
Mahoney 1 linked to an N-terminal ubiquitin (Ub) (58). A C-terminal GSSS-His6 tag and 
a 3Dpol L446D point mutation, which interrupts the Interface I (67, 152) interaction so 
that the polymerase can function as a monomer, were added. The ubiquitin is co-
translationally cleaved by a ubiquitin-specific carboxyl-terminal protease to generate an 
authentic 3Dpol N-terminus with glycine as its first residue (58).  
2.1.2 pRNA2 
 pRNA2 was supplied by David J. Barton (University of Colorado, Aurora). 
pRNA2 contains sub-genomic wild-type PV cDNA with a deletion of the capsid genes, 
nucleotides 1175-2956 (36). The 5' end has two non-viral guanosines which are required 
for in vitro T7 RNAP based transcription of the plasmid into viral RNA. T7 transcription 
of MluI-linearized pRNA2 results in a wild-type PV, positive-strand, replicon. The two 
non-viral guanosines at the 5’ end of  the transcripts allow authentic replication of 
negative-strand RNA in the cell-free system, but inhibit initiation of subsequent positive-
strand synthesis (24). 
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3Dpol mutations were generated using the QuikChange Site-Directed Mutagenesis 
Kit protocol (Stratagene, Inc.) and verified by sequencing. Plasmids were isolated from 
E.coli and digested with KasI and MluI to produce a minimal fragment containing the 
desired 3Dpol mutation and this fragment was sub-cloned into the full-length pRNA2 
vector that has not undergone PCR to decrease the chance of introducing additional point 
mutations.  
2.1.3 pGRNA2-polio 
 pGRNA2-polio was generated from pGEM-polio provide by the Kirkegaard Lab. 
pGEM-polio contains the full PV open reading frame to generate fully infectious virus 
(45). The 5’ end contains two non-viral guanosines, required for in vitro transcription via 
T7 RNAP. The two non-viral guanosines are maintained after T7 transcription resulting 
in a quasi-infectious virus after transfection. However, after only a few replications of the 
genome the non-viral guanosines are lost and viral replication occurs as normal (69). 
 pGRNA2-polio and 3Dpol mutations were sub-cloned from pRNA2 plasmid 
digested with KasI or BglII and MluI. The pGRNA2 plasmid has a longer poly(A)80 (80 
adenosine) tail than the original pGEM-polio. Mutant plasmids are named pG for pGEM, 
3D to indicated mutated protein followed by residue, position, and mutation, e.g. 
pG3DW5F.  
2.2 Protein Expression and Purification 
pET26bUbDH containing PV 3Dpol, was transformed  into E. coli BL21 (PCG1) 
cells for expression.  By this method, 3Dpol is initially translated as an ubiquitin fusion 
protein that is then cleaved in vivo by co-expressed ubiquitin-specific carboxyl terminal 
protease Ubp1, resulting in full-length polymerase with the native N-terminal glycine 
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residue (58). Cells were grown overnight at room temperature in NZCYM medium with 
25 µg/ml kanamycin, 20 µg/ml chloramphenicol, and 0.4% (w/v) D-glucose to reach an 
OD600 of ≈1.0 and 5 ml of the overnight culture was then used to inoculate 1 liter of 
NZCYM medium with 25 µg/ml kanamycin. The cells were grown at 37 °C to an OD600 
of 0.6-0.8, cooled to room temperature, IPTG was added to a final concentration of 0.5 
mM, and the cells were grown for an additional 12-18 hours. The resulting cell pellet was 
resuspended in a lysis buffer of 50 mM Tris, pH 8.0, 300 mM NaCl, 20% (v/v) glycerol, 
and 0.02% (w/v) NaN3 and lysed at 18000 psi in a model M-110L microfluidizer 
(Microfluidics, Newton, MA). The lysate was centrifuged for 40 minutes at 17,000 rpm 
in a Sorvall SS-34 rotor and the supernatant was loaded onto a nickel charged Chelating 
Sepharose Fast-Flow column (GE Healthcare), followed by step elution with 350 mM 
imidazole in 50 mM Tris, pH 8.0, 300 mM NaCl, 20% (v/v) glycerol, and 0.02% (w/v) 
NaN3. Fractions containing the polymerase were pooled and diluted to reduce the NaCl 
concentration to ≈0.11 M prior to loading onto a HiTrap Q HP column (GE Healthcare) 
and eluting with a linear gradient to 1 M NaCl in 25 mM Tris, pH 8.5, 20% (v/v) 
glycerol, 0.02% (w/v) NaN3. The pooled fractions were concentrated to ≈0.8 ml and run 
over a Superdex 200 gel filtration column (GE Healthcare) equilibrated in 200 mM NaCl, 
20% (v/v) glycerol, 5 mM Tris, pH 7.5, 0.02% (w/v) NaN3. Pooled fractions were 
supplemented with 5 mM TCEP, concentrated to ≈400 μM, flash frozen with liquid 
nitrogen, and stored at -80 °C in 5-10 μl aliquots. Protein concentrations were determined 
based on absorbance at 280 nm and extinction coefficients were calculated based on the 
amino acid sequence using the ExPASy Proteomics Server 
(http://www.expasy.ch/tools/protparam.html). 
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2.3 RNA Oligonucleotides 
2.3.1 IRdye labeled RNA 
RNA oligonucleotides were synthesized by Integrated DNA Technologies 
(www.idtdna.com) with an amino modifier deoxythymidine residue at the variable N 
position of the GNRA-type RNA tetraloop (i.e. GTAA) (Fig. 2.1). The oligonucleotides 
were labeled at this site with IRdye 800RS NHS ester (LI-COR Biosciences) in a buffer 
containing 200 mM Na2CO3/NaHCO3, pH 9.5, and 12.5 mM EDTA, ethanol precipitated, 
resuspended in TE buffer, and any remaining unreacted label was removed via Biospin 
P6 columns (Bio-Rad).  Labeling efficiency was determined by the relative absorbance of 
the final material at 260 nm and 767 nm. The intramolecular hairpin structure that serves 
as a 3Dpol primer-template was formed by heating the RNA to 95°C for 3 minutes in 50 
mM NaCl, 5 mM MgCl2, 10 mM Tris, pH 8.0, followed by snap cooling on ice, which 
favors the intermolecular hairpin rather than the formation of oligomeric dimers.  
2.3.2 Fluorescein labeled RNA 
 5’ fluorescein labeled RNA oligonucleotides were synthesized by Integrated DNA 
Technologies (www.idtdna.com) (Fig. 2.2A). The RNA was resuspended in TE buffer (1 
mM EDTA, 10 mM Tris, pH 8.0) then heated to 95oC for 3 minutes and snap cooled on 
ice to fold the elongation competent PETE (Polymerase Template Elongation Element) 
RNA. 
2.3.3 2-aminopurine labeled RNA 
 RNA templates containing the 2-aminopurine nucleotide analogue were 
synthesized by Dharmacon RNAi Technologies (Thermo Scientific, 
www.dharmacon.com) (Fig. 2.2B). The intramolecular hairpin structure was formed by 
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FIG 2.1. IRdye label and thymidine modification. (A) IRdye 800RS labeled 
used in labeling modified thymidine. Image from LI-COR website 
www.licor.com. (B) C6 dT amino modified base in GTAA tetraloop to attach LI-
COR IRdye for RNA detection. Image from IDT website, www.idtdna.com. IRdye 





FIG 2.2. Fluorophores used in elongation, binding and EC formation assays. 
(A) Fluorescein used to label 5’ end of 10_26 and 8_6 PETE RNAs in elongation 
and RNA binding assays (B) 2-aminopurine adenine base analogue used as 
fluorescent reporter in 2-aminopurine elongation and complex formation assays.  
A B 
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heating the RNA to 95°C for 3 minutes in 50 mM NaCl, 5 mM MgCl2, 10 mM Tris, pH 
8.0, followed by snap cooling on ice.  
2.4 RNA Binding Assay 
RNA binding reactions were performed as previously described using 10 nM 8-6 
PETE RNA which has a 8 bp hairpin stem with a 6 nt template in 75 mM NaCl, 50 mM 
HEPES, pH 6.5, 1.5 mM MgCl2, 0.1% NP40, 4 mM DTT (Fig. 2.3) (99). Fluorescence 
polarization data were collected in a Perkin-Elmer Victor V multimode microplate reader 
using black 384-well polystyrene plates.  RNA dissociation constants were determined by 
curve fitting the data to a single-site binding isotherm with a Hill coefficient to account 
for the apparent cooperativity of the polarization data using Kaleidagraph (Synergy 
Software). 
2.5 Elongation Complex Formation 
2.5.1 EC formation on IRdye labeled single stranded RNA templates 
Elongation complex formation assays were performed using two different RNA 
molecules in the same reaction to allow us to determine the formation rates of the +1 and 
+2 complexes simultaneously. PETE RNA molecules used in these experiments were 
9+2-24 and 10+1-12 (Fig. 2.3A), which are named using a X+Y-Z convention, where X is 
the number of base pairs in the priming stem, Y is the number of nucleotides that are 
incorporated into the RNA to form the “locked” elongation complex, and Z is the number 
of remaining nucleotides in the single stranded template. Both RNAs contain a unique 
guanosine as the sixth nucleotide from the 5’ end, allowing us to pause elongation at this 
point and avoid any end effects by omitting CTP from the reaction.  Elongation 
complexes were formed by mixing 15 μM 3Dpol, 1 μM each 10+1-12 and 9+2-24 RNA, 
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A 
FIG 2.3. RNA Polymerase Elongation Template Elements (PETE). 
(A) IRdye labeled RNA used for EC formation and stability assays. The 
nucleotides in grey indicate elongation upon incubation with GTP, ATP and UTP. 
Asterisk indicates modified base for IRdye label. (B) IRdye labeled RNA used for 
downstream duplex assays. The nucleotides colored blue indicate elongation upon 
incubation with GTP, ATP and CTP. (C) RNA templates containing 2-aminopurine 
(2AP) nucleotide analogue for downstream interaction assays. (2AP) is 
represented in green. In all RNA templates the nucleotides incorporated during 


















and 40 μM each ATP and GTP in a reaction buffer of 75 mM NaCl, 50 mM HEPES, pH 
6.5, 1.5 mM MgCl2, and 5 mM TCEP.  Elongation complex reactions were quenched at 
the indicated times by addition of an equal volume of quench buffer consisting of 20 mM 
EDTA, 50 mM HEPES, pH 6.5, 75 mM NaCl. Identical reactions also containing 40 µM 
UTP were carried out to follow the direct formation of longer +7 or +20 products that 
stop six nucleotides from the end of the template.  Reaction products were separated on 
15% polyacrylamide, 7M urea gels that were imaged using a LI-COR Odyssey Infrared 
Imager 9120 and quantified using the manufacturer’s Odyssey software. Data from 
PAGE was plotted as percentage of total RNA that elongated at each time point and fitted 
to a single exponential curve, A*(1-exp-t/τ)+C, where τ is the time constant for complex 
formation. 
2.5.2 EC formation IRdye labeled downstream duplex RNA 
Elongation complex formation assays were performed as described above on 
RNA containing downstream duplex. PETE RNA molecules used in these experiments 
were dblPETE 8+4_0+9, dblPETE 8+4_3+8 and PETE 8+4_3_3 (Fig. 2.3B). These RNA 
templates are named by an X+Y_A+B, or X+Y_Z_Z for the control, convention where X 
is the number of nucleotides in the 3’ hairpin, Y is the number of nucleotides incorporated 
during complex formation, A is the number of single stranded nucleotides at the 5’ end, B   
is the number of base pairs in the downstream hairpin. The “dblPETE” or double PETE 
designates RNA templates that have downstream duplex and PETE 8+4_3_3 served as a 
control having the same overall sequence with no downstream duplex.   Elongation 
complexes were formed by mixing 15 μM 3Dpol, 1 μM each RNA, and 40 μM each ATP 
and GTP in a reaction buffer of 75 mM NaCl, 50 mM HEPES, pH 6.5, 1.5 mM MgCl2, 
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and 5 mM TCEP.  Elongation complex reactions were quenched at the indicated times by 
addition of an equal volume of quench buffer consisting of 20 mM EDTA, 50 mM 
HEPES, pH 6.5, 75 mM NaCl.  Reaction products were separated on 15% 
polyacrylamide, 7M urea gels that were imaged using a LI-COR Odyssey Infrared 
Imager 9120 and quantified using the manufacturer’s Odyssey software. Data from 
PAGE was plotted as percentage of total RNA that elongated at each time point and fitted 
to a single exponential curve, A*(1-exp-t/t)+C, where τ is the time constant for complex 
formation. 
2.5.3 EC formation on 2-aminopurine RNA templates 
 Elongation complex formation of 2-aminopurine containing RNA was performed 
in an Applied Photophysics SX-20 stopped-flow instrument where equal volumes of 
3Dpol-RNA complex were mixed with or without ATP and GTP. 45 µM 3Dpol and 2.5 µM 
9+4apN_13 RNA were added in a reaction buffer of 75 mM NaCl, 50 mM HEPES, pH 
6.5, 1.5 mM MgCl2, and 5 mM TCEP. Reactions were incubated on ice for 20 minutes 
followed by a 22oC incubation for 10 minutes. The RNA templates were named in an 
X+YapN_Z format where X is the number of base pairs in the priming stem, Y is the 
number of nucleotides that are incorporated into the RNA to form the locked elongation 
complex, Z is the number of remaining nucleotides in the single stranded template and 
apN indicates the position of the 2-aminopurine after the locked complex formation (Fig. 
2.3C). The stopped-flow instrument was set for excitation at 315 nm and emission 
detection using a 370-nm high pass filter. Reactions were loaded into reaction syringe 
and equal volume of RNA-protein complex and 80 µM ATP and GTP were mixed, for a 
2 fold dilution and total fluorescence was monitored for evaluation. 
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2.6 RNA Elongation 
2.6.1 Fluorescein labeled RNA elongation 
Elongation rates were measured at 22.5 °C in an Applied Photophysics SX-20 
stopped-flow instrument where equal volumes of pre-formed 3Dpol-RNA elongation 
complex with 10-26 PETE RNA (Fig. 2.4A) and NTP solutions were mixed to initiate the 
reaction (59). Fluorescence excitation was at 492 nm from a monochromator source with 
bandwidth set to 9.3 nm and emission from fluorescein was detected using 515 nm high 
pass filters. Total fluorescent (TF) and fluorescence anisotropy (FA) signals (Fig. 2.4B) 
were calculated from the parallel and perpendicular polarization signals after background 
and G-factor correction, as per standard fluorescence methods (84). Stable +1 elongation 
complexes were assembled prior to the elongation reaction using a 30-minute incubation 
with 15 µM polymerase, 1 µM RNA and 20 µM ATP and then diluted 10-fold in reaction 
buffer and stored on ice until being loaded into the stopped flow instrument.  Once 
loaded, the samples were allowed to temperature equilibrate for at least five minutes prior 
to data collection. The final solution measured in the stopped flow experiment after rapid 
mixing contains 50 nM RNA, 750 nM polymerase and 5–120 μM each NTP in reaction 
buffer. Elongation rates in nucleotides per second were calculated from the length of the 
lag phase observed at of each NTP concentration and plotted against substrate 
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FIG 2.4. RNA elongation using 5’ fluorescently labeled PETE. (A) Cartoon 
representation of 5’ fluorescein labeled PETE RNA. The red nucleotide represents 
elongation complex formation. (B) Raw data showing the fluorescence signal 
change during elongation of PETE 10_26 RNA obtained in a stopped-flow, y-axis. 
y2-axis indicates the intermediate population characterizes as PETE 10_26 is 





2.6.2 2-aminopurine elongation 
 Elongation of RNA templates containing 2-aminopurine were measured by an 
Applied Photophysics SX-20 stopped-flow instrument where equal volumes of pre-
formed 3Dpol-RNA elongation complex with 9+4apN_13 (Fig. 2.5A) and NTP solutions 
were mixed to initiate the reaction. Elongation complexes were pre-formed prior to 
injection by the incubation on 15 µM 3Dpol, 5 µM RNA and 40 µM each ATP and GTP  
in 75 mM NaCl, 1.5 mM MgCl2, 4 mM TCEP and 50 mM HEPES pH 6.5. The 
complexes were incubated on ice for 20 minutes and then at 22oC for 10 minutes. The 
reactions were loaded into the injection port for data collection. Fluorescence excitation 
was at 315 nm and emission was detected with 370 nm high pass filter. TF data was 
acquired after background auto correction (Fig. 2.5B). 
2.7 Elongation Complex Stability 
Elongation complexes were formed as described above in section 2.4.1 for the 
9+2_24 RNA template and section 2.4.2 for 8+4_0+9, 8+4_3+8 and 8+4_3_3 RNA (Fig. 
2.3). RiboLock RNase Inhibitor (Fermentas) was added to 3 units/µl with a room 
temperature incubation period of 5-15 minutes, depending on complex formation rates 
from Tables 3.1 and 5.1. Reactions were then diluted up to 10-fold in reaction buffer 
consisting of 50 mM HEPES, pH 6.5, 5 mM TCEP, 1.5 mM MgCl2 and either 75 mM or 
325 mM NaCl (300 mM NaCl final concentration) to limit polymerase-RNA rebinding 
and reinitiation.  For the 9+2_24 template, dilutions were also carried out in 75 mM NaCl 
with 100 ng/µl heparin to prevent RNA rebinding, and an equivalent concentration of the 
10+1-12 RNA was added to the reaction immediately after the dilution step to serve as a 




FIG 2.5. 2-aminopurine PETE RNA  elongation fluorescence. (A) Cartoon of 
RNA used for elongation, experiment shown in panel B. (B) Fluorescence signal 
collected in stopped flow  instrument using 370 high pass filter. Data is from 5 µM 
pre-locked PETE 9+4ap3_13 elongation by 15 µM wild-type 3Dpol upon addition 
of 5 µM NTPs. Labels +3, +2 and +1 to -1 indicate fluorescence of 2AP when at 
























reaction were chased to longer full-length products, unless specified otherwise, by the 
addition of an equal volume of 40 μM UTP solution, resulting in 20 μM final 
concentrations of GTP, UTP and ATP; elongation to product was allowed to proceed for 
3 or 5 minutes. For 9+4_24, CTP was omitted from the chase step to stop the reaction six 
nucleotides from the end of the template strand and avoid potential end effects. Reaction 
products were analyzed by denaturing PAGE and the fraction of active elongation 
complexes was determined by dividing the amount of elongated RNA by the sum of the 
fully elongated and non-elongated RNA. Data analysis by exponential curve fitting was 




 Elongation complexes were assembled as described above in 75 and 300 mM 
NaCl without heparin, diluted 10-fold and incubated at either room temperature or 37 °C, 
and at various time points (0-180 minutes) after the 10-fold dilution samples were taken 
and centrifuged at 17,000 x g for 10 minutes at 4oC.  The supernatant was removed and 
soluble protein was analyzed by SDS-PAGE stained with Coomassie Brilliant Blue.  
2.9 Elongation Processivity 
2.9.1 Primer extension 
 DNA primers SpeI-2201 (5’- 2073 ACTCTATGTAATTGGTGATGCCTTGTTCC 
ATGG2040-3’) and AvrII-5424 (5’-4521TCTTTAGTCCATTATTGATTCATGAA5394-3’) 
were designed to anneal to the 3’ end of a T7 transcribed PV sub-genomic replicon after 
linearization with SpeI at nucleotide 2201 and AvrII at nucleotide 5242 at a position in 
the RNA template with extensive base repeats (GAGAn) so that the elongation complex 
could be formed and stalled. DNA primers were ordered from Integrated DNA 
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Technologies (www.idtdna.com) with a 5’ LI-COR label. RNA template strands were T7 
transcribed from pRNA2 plasmid linearized by SpeI, or AvrII to generate 2201 and 5424 
nucleotide RNA products, respectively (Fig. 2.6 B). DNA primers were annealed to the 
RNA template by mixing  0.5 µM RNA template with 0.5 µM DNA primer in 16 mM 
NaCl, 1.6 MgCl2 1.6 mM TRIS pH 7.5 and 2% v/v RiboLock RNase inhibitor 
(Fermentas) (159). Annealing reactions were then heated to 90oC and step cooled to 30oC 
in 0.33 degree per minute increments. Annealing efficiency was determined by native 
0.7% agarose gel electrophoresis. Primer extensions followed by agarose gel 
electrophoresis were performed by incubation 0.4 µM primer/template substrate, 10 µM 
3Dpol and 40 µM each ATP, UTP, GTP and CTP formation buffer (75 mM NaCl, 4 mM 
TCEP, 4 mM MgCl2 and 50 mM HEPES pH 6.5) on ice for 20 minutes followed by a 
room temperature incubation at 30-35 minutes. Reactions were quenched by the addition 
of an equal volume of high salt buffer (600 mM NaCl, 20 mM EDTA, and 50 mM 
HEPES, final). 50% of the reaction volume was loaded on to a native 0.7% agarose gel 
and separated by electrophoresis. Gels were imaged using a LI-COR Odyssey Infrared 
Imager 9120 and quantified using the manufacturer’s Odyssey software then EtBr stained 
and imaged again using UVP Bioimaging System and LightLabs software. Primer 
extensions analyzed by PAGE were performed by pre-incubation of 0.25 µM 
primer/template substrate, 20 µM 3Dpol and 500 µM each of CTP and UTP in formation 
buffer to make the stalled elongation complex. Reactions were then incubated on ice for 
20 minutes then moved to room temperature and incubated for 40 minutes. Reactions 
were then diluted 5-fold into high salt buffer (300 mM NaCl final) containing 125 µM of 
ATP and GTP for a final NTP concentration of 100 µM. 
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FIG. 2.6. Poliovirus RNA genome used for processivity experiments.  
(A) Genomic RNA 5’ NTR (non-translated region) with cloverleaf and IRES 
(internal ribosome entry site) RNA secondary structures.  Followed by the ORF, 
missing the capsid domain, and 3’ NTR. Red bars indicated restriction enzyme cut 
sites : SpeI, 2201 nt; AvrII, 5424 nt; MluI, 5742 nt. (B) RNA template used in 
primer extension assays. DNA primers are represented by purple arrows. Number 
represents the nucleotide cut site and 5’ position of DNA primer.  (C) Self-priming 
RNA. Hairpin forms at the 3’ end. Numbers represent cut site. (D) Removal of 





AvrII linearized SpeI linearized 
AvrII linearized SpeI linearized 
AvrII linearized AatII digested 
5’ NTR 3’ NTR ORF 
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2.9.2 Self-priming RNA 
RNA transcripts were T7 transcribed from pRNA2 plasmid linearized by SpeI, 
AvrII, or MluI to generate 2201, 5424, or 5742 nucleotide RNA products, respectively 
(Fig. 2.6A and C). For experiments the required deletion of the 5’ NTR, quick-change 
PCR amplification was performed inserting an AatII restriction enzyme cut site 15 
nucleotides into the cDNA on the pRNA2 plasmid (qc-aatII ins pRNA2). The pRNA2 
plasmid was digested with the AatII restriction enzyme to remove nucleotides 15-1123 of 
the PV genome, this fragment was separated by gel purification and the large fragment 
containing the remainder of the RNA genome was purified and circularized using T4 
ligase and reaction buffer from New England Biolabs (Fig. 2.6D). For transcription, the 
plasmid now called pRNA2-I (for pRNA2 minus IRES) was linearized by the AvrII 
restriction enzyme, as described above. These RNA transcripts initiate elongation 
complex formation via snap-back priming from the 3’ end of the transcripts. Elongation 
reactions were initiated by incubating 20 µM protein, 0.4 µM RNA and 500 mM each 
NTP at room temperature for 7-15 minutes in buffer containing 50mM NaCl, 1.5 mM 
MgCl2, 4 mM TCEP, 50 mM HEPES pH 6.5, and 1 units/µl RiboLock RNase inhibitor 
(Fermentas).  The resulting elongation complexes were then diluted five fold into a high 
salt buffer (356 mM NaCl [300 mM final], 200 mM NTPs, 1.5 mM MgCl2, 4 mM TCEP, 
50 mM HEPES pH 6.5) to allow elongation to the end of the template without further 
initiation. Reaction samples were quenched with 16 mM ETDA after various times, 
phenol:chloroform:isoamyl alcohol extracted, precipitated and relative product RNA 
lengths were analyzed by native gel electrophoresis in an ethidium bromide stained, 0.7% 
agarose gel.  
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2.10 Cell-Free Replication 
 These experiments were performed by me under the mentorship of Ben Steil in the 
Barton lab at the University of Colorado Health Sciences Center, in Aurora, CO. 
pRNA2, referred to as wild-type, encodes a poliovirus RNA replicon from which 
the P1 capsid genes have been deleted (nucleotides 1175 to 2956) (36). The T7 
transcription of MluI-linearized pRNA2 cDNA yields positive-sense replicon RNA, 
which was used to program HeLa cytoplasmic extracts.  
Cytoplasmic extracts and translation initiation factors were prepared from HeLa 
cells as previously described (23). Reactions contained 50% cytoplasmic extract, 20% 
initiation factors, 1x nucleotide reaction mix (10mM ATP, 2.5 mM GTP, and 2.5 mM 
CTP; 600 mM KCH3CO2; 300 mM creatine phosphate; 4 mg/ml creatine kinase; and 155 
mM HEPES-KOH, pH 7.4), and T7 transcripts of poliovirus replicon RNA at 45 µg/ml.  
Pre-initiation RNA replication complexes were formed in the presence of 2 mM 
guanidine HCl as previously described (21).  
Viral protein synthesis from poliovirus replicon mRNA was monitored by 
incorporation of [35S] methionine (1.2 mCi/ml), which was quantified by acid-
precipitation followed by scintillation counting. Pre-initiation replication complexes were 
isolated from HeLa S10 reactions mixtures and resuspended in [α-32P] NTP-labeling 
reaction mix (27 mM HEPES-KOH, pH7.4; 60 mM KCH3CO2; 2.3 Mg(CH3CO2)2, 2.6 
mM dithiothreitol, 2.3 mM KCl; 50 µg/ml puromycin; 1 µCi/µl [α-32P] UTP (10 µM 
labeled UTP), 1 mM ATP, 250 µM GTP and CTP; with or without 2mM guanidine HCl), 
and incubated at 37oC for indicated time periods.  Replication complexes were isolated 
by centrifugation at 17,000 x g for 15 min at 4oC, resuspended in 0.5% SDS buffer (0.5% 
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SDS, 1 mM EDTA, 100 mM NaCl, 10 mM Tris, pH7.5,), phenol-chloroform extracted, 
ethanol precipitated, and the resulting product RNA was analyzed by nondenaturing 1% 
agarose 1x Tris-borate-EDTA (TBE) gel electrophoresis. The agarose gel was dried and 
radiolabeled product RNA was detected by phosphorimaging.  
2.11 Transfection of HeLa Cells and Virus Quantification 
With the exception of cDNA plasmid mutagenesis, these experiments were 
performed by Dr. Brian Kempf in the Barton lab at the University of Colorado Health 
Sciences Center, Aurora, CO. 
Residue 5 mutations were introduced into poliovirus cDNA by subcloning from 
pRNA2 via the KasI and MluI restriction sites. Poliovirus RNA encoding wild-type, 
Trp5Phe, or Trp5Leu 3Dpol were derived by T7 transcription of MluI linearized cDNAs 
(Type 1 Mahoney). HeLa cells (~106 cells per 35mm well) were transfected with 2 µg of 
poliovirus RNAs using Transmessenger transfection reagent (Qiagen) according to 
manufacturer’s instructions. Transfected HeLa cells were grown in 2 ml of cell culture 
media (DMEM containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml 
streptomycin) and incubated at 37oC. Cells were examined for cytopathic effect (CPE) at 
24, 48, and 72 hours post-transfection (hpt).  At 48 and 72 hpt the cells were subjected to 
3 cycles of freeze-thaw. Poliovirus titers at 48 and 72 hpt were determined by plaque 
assay as previously described (66). 
2.12 Sequence of 3D
pol
 cDNA from Virion RNA 
These experiments were performed by Dr. Brian Kempf in the Barton lab at the 
University of Colorado Health Sciences Center, Aurora, CO. 
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Poliovirus RNA was isolated from purified virus particles and converted into 
cDNA for sequencing. In brief, poliovirus from transfections and infections was purified 
from cell culture media by layering 8 ml of the virus onto 3 ml 30% (w/v) sucrose in PBS 
followed by centrifugation at 36,000 rpm for 4 hours at 4oC using a Beckman SW41 
rotor. The pelleted virus particles were resuspended in 400 µl 0.5% SDS buffer (0.5% 
SDS, 10 mM Tris-HCl, pH7.5 100 mM NaCl). PV RNA was isolated by 
phenol:chloroform:isoamyl alcohol extractions and ethanol precipitation.  
Poliovirus RNAs were transcribed into cDNA using Superscript III Reverse Transcriptase 
(Invitrogen) and a primer complementary to nucleotides 6930 to 6947 of the poliovirus 
open reading frame (5’-6947GGTGGTCTAAATCTATGC6930-3’). cDNA corresponding to 
the 3D
pol
 region of poliovirus RNA was amplified by 35 PCR cycles with high fidelity 
PHUSION DNA polymerase (New England Biolabs) using a forward primer (5’-
5284GGCAATGACAATTCTACAAGC5304-3’) and a reverse primer (5’-
6519GCTTCAATTAATCTGGATTTC6497-3’) complementary to the indicated poliovirus 
RNA sequences. PCR products were sequenced using the forward primer corresponding 
to poliovirus nucleotides 5816-5838. When mixed populations of virus sequence were 
detected in the sequence of PCR products (as for Trp5Leu at 48 hpt), PCR products were 
TOPO-TA cloned (Invitrogen) and the sequences of representative cDNA clones were 
determined. PCR products and cDNA clones were sequenced in the University of 





Chapter 3  
 Poliovirus Polymerase Residue 5 Plays a Critical Role in Elongation Complex 
Stability 
3.1 Introduction 
 This chapter has been published as part of  Hobdey, S.E., Kempf, B.J., Steil, B.P., 
Barton, D.J., and Peersen, O.B. (2010) J Virol 84,8072-8084.  
 The work in this chapter was completed by me, Sarah E. Hobdey. Contributions 
from other authors can be found in Chapter 4 of this dissertation. 
Members of the Picornaviridae family of small RNA viruses cause a wide range 
of diseases in humans, including liver disease, heart disease, aseptic meningitis, the 
common cold, and poliomyelitis. The picornaviruses include the most common human 
viruses, the rhinoviruses that spread through respiratory pathways and the second most 
common, enteroviruses that spread by fecal-oral transmission. These viruses have ≈7.5 
kB positive-sense genomes containing a single large open reading frame encoding for a 
≈250 kDa polyprotein that is cleaved into about a dozen different proteins by viral 
proteases (77).  Their genome lifecycle is completely RNA based, with replication being 
driven by the viral 3Dpol protein, an RNA-dependent RNA polymerase (RdRP).  
After viral RNA translation and polyprotein processing, 3Dpol replicates the 
infecting positive-strand RNA template into a negative-strand intermediate that is 
subsequently used as a template for positive-strand synthesis. During these processes, 
3Dpol interacts with multiple templates, substrates and other viral proteins; however, 
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many aspects of these events remain obscure. The crystal structures of several 
picornavirus 3Dpol enzymes have been solved and these all conform to the “right hand” 
analogy commonly used to describe polymerases as having palm, thumb, and fingers 
domains (32, 54, 64, 92, 110, 152).  Based on the recently publish PV 3Dpol elongation 
complex structure and homology to other polymerases, the fingers domain interacts with 
template RNA, the palm domain contains the active site aspartate residues that coordinate 
the metals needed for catalysis, and the pinky and thumb domains contact the exiting 
duplex RNA product in a clamp-like structure (60). This is similar to structures of the 
closely related foot-and-mouth disease and Norwalk viruses solved in complex with 
nucleic acids (53, 109, 163). 
Poliovirus is among the most studied picornaviruses and its polymerase has been 
thoroughly characterized biochemically (11, 57) and structurally (151, 152).  Processive 
RNA synthesis requires the formation of a stable 3Dpol elongation complex through a 
multi-step process involving at least two conformational changes (9, 60).  First, following 
RNA binding there is a slow (t1/2 ≈12 sec) conformational change that results in a 3Dpol 
RNA complex poised for NTP incorporation. Second, following the addition of the first 
nucleotide to the primer there is another conformational change to produce a very stable 
elongation complex with an in vitro half-life on the order of several hours. The 
polymerase begins processive elongation after the formation of this stable elongation 
complex and each nucleotide addition cycle involves a five step mechanism, of which 
NTP repositioning and NTP catalysis are rate limiting (11).  Similar experiments using 
the homologous foot-and-mouth disease virus polymerase reveal an analogous set of 
complexes resulting in an elongation complex with a half-life of 27 hours (6).  Although 
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these viral polymerase complexes have been well-characterized biochemically, there is 
relatively little known about any structural changes involved in elongation complex 
formation or the catalytic cycle itself; all the 3Dpol structures solved thus far show 
essentially the same conformation with no evidence for significant conformational 
changes upon RNA or NTP binding. 
The activation of several picornavirus polymerases is dependent upon correct 
cleavage of 3Dpol from the viral 3CDpro precursor protein in order to create a new 
N-terminus that can be buried in a pocket at the base of the 3Dpol fingers domain.  This 
buried N-terminus has been observed in polio, coxsackie, rhino, and foot-and-mouth 
disease virus polymerases (32, 54, 92, 152).  In solving the structure of poliovirus 
polymerase, we observed that burying the N-terminus resulted in a subtle but important 
conformational change in the active site whereby Asp238 was repositioned to make a key 
hydrogen bond with the 2’ hydroxyl of a bound NTP (152).  Addition or deletion of a 
single residue at the N-terminus abolished enzyme activity, and mutations of Gly1 to 
alanine resulted in a partially active enzyme with slightly altered positioning of Asp238.  
Further data from coxsackievirus polymerase showed that the addition of a second N-
terminal glycine also inactivated the enzyme, but activity could be restored by also 
deleting Glu2, indicating that there is a specific length requirement in the N-terminal 
sequence of the enzyme (32).  A prime candidate for involvement in such a length 
requirement is residue Phe5 of coxsackievirus 3D
pol
 that corresponds to Trp5 in 
poliovirus 3D
pol
. In the 3D
pol
 structures there is a backbone distortion in the β-strand 
composed of residues 1-9 that results in this large hydrophobic amino acid being solvent 
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FIG. 3.1. Crystal structure showing residue 5 and RNA used for elongation 
complex experiments.. (A) Structure of poliovirus polymerase-GTP complex 
(IRA7) showing the distortion of the β-sheet conformation between residues 3 and 
4 that results in Trp5 being solvent exposed adjacent to a large hydrophobic patch 
composed of residues from the index (green) and middle (orange) fingers. (B) 
Cartoon of the PETE (polymerase elongation template element) RNAs used in 
complex formation assays. Both RNAs are G-less until the 6th nucleotide from the 
end, which limits secondary structure and stops elongation before the 5’ end to 
avoid possible end effects. The * indicates the position of the amino-modified 













unusual conformation at residue 5 is conserved among picornaviral polymerase structures 
and substitution mutations at this residue had significant effects on coxsackievirus 
polymerase activity (32).  Large hydrophobic amino acids at residue 5 increased 3Dpol 
activity while small amino acids at residue 5 decreased 3Dpol activity (32). Based on these 
data we proposed that the 3Dpol catalytic cycle involves a conformational change wherein 
residue 5 flips into an adjacent hydrophobic patch on the polymerase to aid in NTP 
positioning, and such a conformational change would require the N-terminus to be 
correctly buried to act as a stable pivot for the rotational movement.  
In this work we have investigated the role of residue 5 in 3Dpol in further detail by 
examining how a series of mutations in poliovirus 3Dpol affect RNA binding, elongation 
complex formation, elongation rate, and elongation complex stability.  The data show 
that residue 5 mutations have major effects on the stability of the elongation complex 
with minor effects on elongation complex formation and no effect on RNA binding 
affinities and elongation rates.   
3.2 Results 
3.2.1 Residue 5 mutations were made to PV 3Dpol 
 Residue 5 point mutations were introduced in the PV 3Dpol using quick change 
PCR, as described in Chapter 2 Section 2.1.1. The rationale behind selected PV residue 5 
mutations was based on work done in Coxsackievirus; planar hydrophobic residues at 
position 5 resulted in active polymerase while small hydrophobic residues decreased 
activity (32). DNA mutations were designed so that the maximum number of nucleotides 
in the codon sequences were mutated to reduce the chances of reversions when 
introduced into the full virus (Chapter 4).  
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3.2.2 Residue 5 mutants have no effect on RNA binding and little effect on elongation 
complex formation compared to wild-type 
The effects of residue 5 mutations on polymerase RNA affinity were determined 
using a fluorescence polarization based PETE binding assay with residue 5 mutations to a 
planar aromatic phenylalanine and a smaller non-planar valine residue, described in 
Chapter 2, Section 2.4.  Neither mutation had a significant effect on the affinity for PETE 
8-10 RNA (Table 2), indicating that residue 5 does not play a direct role in RNA binding 
in the absence of nucleotides and elongation.  We then examined what effects the 
mutations have on formation of stable 3Dpol elongation complexes as measured by the 
incorporation rate for the initial nucleotides on a self-priming PETE RNA, as described in 
Chapter 2, Section 2.5.1.  Two PETE RNAs were used simultaneously in these 
experiments: one has a 10 bp hairpin followed by a 13 nt template that allowed the 
incorporation of only a guanosine when incubated with GTP and ATP, and the other has 
a 9 bp hairpin with a 26 nt template that allowed the incorporation of both adenosine and 
guanosine (Fig. 3.1B). This RNA design allowed us to compare the two RNAs in the 
same reaction to determine if there are differences between +1 and +2 product formation. 
The final products of the elongation complex formation reaction have identical structures 
and differ only in the length of their remaining template. Product formation rates were 
determined by polyacrylamide gel analysis of the quenched samples followed by band 
quantitation of the IRdye labeled RNAs to determine the relative amounts of starting and 
elongated material (Fig. 3.2A).  
The formation rates for the +1 and +2 products by wild-type 3Dpol and the various 

















Trp5Leu  3Dpol 
B 
FIG. 3.2. Elongation complex formation. (A) Denaturing PAGE showing the 
time course for formation of the +1 and +2 products from the two RNAs. 
Elongation complexes were formed by incubating 1 µM of each PETE RNA, 15 
µM 3Dpol, and 40 µM of ATP and GTP at 22 °C for various times as indicated. (B) 
Kinetics of +2 complex formation rates obtained from band intensity data curve fit 





Table 3.1. Initiation product formation rates of Trp5 mutantsc 
a Product formation in the presence of 40 µM each ATP and GTP only. 
b Product formation in the presence of 40 µM each ATP, GTP and UTP. 










wild-type 2.0 ± 0.1 2.5 ± 0.5 3.0 ± 0.2 3.0 ± 0.5 
Trp5Tyr 4.5 ± 0.5 5.5 ± 0.1 4.2 ± 0.3 4.0 ± 0.5 
Trp5Phe 4.0 ± 0.1 7.5 ± 0.5 5.9 ± 0.5 9.0 ± 1.5 
Trp5Leu 5.5 ± 0.5 4.0 ± 0.5 9.4 ± 0.6 5.0 ± 1.0 
Trp5Val 7.0 ± 0.5 5.0 ± 0.5 8.5 ± 0.3 8.0 ± 0.5 
Trp5Ala 7.5 ± 0.5 7.5 ± 0.5 6.6 ± 0.7 7.5 ± 0.5 
Initiation product formation rate (minutes) 
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exponential kinetics for +1 and +2 product formation and the rates were determined by 
numerical curve fitting. The Trp5 mutations reduced both the +1 and +2 complex 
formation rates when compared to wild-type, but the effects were fairly small with only a 
≈3-fold reduction at most (Table 3.1).  The rate reduction also correlated with the size of 
the replacement residue, with tyrosine and phenylalanine having fairly small effects while 
leucine, valine, and alanine had greater effects.  Prior studies of 3Dpol enzymology have 
shown that the incorporation of the first nucleotide is the rate-limiting step during 
initiation that is followed by the fast incorporation of additional nucleotides (13).  
Consistent with this, the rates for formation of the longer +7 and +20 products in the 
presence of ATP, GTP, and UTP are comparable to those of the +1 and +2 product 
formation for each polymerase (Table 3.1). 
3.2.3 Residue 5 mutants have no effect on elongation rate 
 To determine 3Dpol elongation rates we used the PETE assay in a stopped-flow 
kinetic format where we detect how long it takes 3Dpol to reach the end of a 5’ fluorescein 
labeled template RNA, methods described in Chapter 2, Section 2.6.1 (59). The 
experiments utilized a 10-26 PETE RNA with a 10 bp priming hairpin and a 26 
nucleotide G-less template sequence designed to minimize the possibility of secondary 
structure (Fig. 3.3A). For these experiments, stalled +1 elongation complexes were 
generated prior to the stopped-flow experiment. The stopped-flow data traces show an 
initial lag phase that is followed by an increase in anisotropy as the polymerase reaches 
the end of the template and immobilizes the fluorescein label (Fig. 3.3B).  The length of 
the lag phase is indicative of the time required for the polymerase to elongate through the 
twenty nucleotide portion of the template, allowing for the calculation of an elongation 
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A 
FIG. 3.3. 3Dpol elongation rates.  (A) Schematic of 5’ fluorescein (F) end-labeled 
PETE RNA used to determine elongation rate by stopped-flow fluorescence 
anisotropy. (B) Normalized anisotropy data showing the signal increase during 
elongation of 10-26 PETE RNA by Trp5Phe 3Dpol at various concentrations of 
NTPs. The lag phase represents elongation through the 20 nucleotide G-less 
segment of the template, which shortens with increasing NTP concentration due to 
faster elongation rates. The increase in anisotropy signal is associated with the 
addition of the terminal 5 nucleotides as the polymerase contacts the fluorescein 
at the 5’ end of the RNA. (C) Michaelis-Menten plot showing the maximum 





















































Vmax: 1.8 ± 0.2 nt/sec 
Kmapp: 10 ± 3 µM 
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rate in nucleotides per second (nt/sec) (59). 3Dpol elongation rates were measured at a 
number of NTP concentrations and plotted as a Michaelis-Menten curve from which Vmax 
and an apparent Km values were determined (Fig. 3.3C, Table 3.2).  The results indicate 
that all of the mutants exhibited essentially wild-type maximal elongation rates (Vmax) 
and apparent Km values of ≈2 nt/sec and 20 µM, respectively, indicating that the nature of 
residue 5 does not significantly affect the 3Dpol elongation rate. Note that these data were 
obtained at 22.5 °C and pH 6.5 to minimize thermal inactivation of the polymerase, but 
faster rates of ≈70 nt/sec are obtained at higher temperature and pH values (59). 
While the Trp5 mutants did not affect 3Dpol elongation rate, we did observe 
significant differences in the amplitudes of the elongation associated fluorescence signals 
from the various Trp5 mutants (Fig. 3.4A).  The amplitude of the elongation dependent 
terminal fluorescence change decreased, particularly for the Trp5Ala mutant, although 
the data traces retained the expected lag phase behavior and maintained sufficient signal-
to-noise to determine elongation rates (Fig. 3.4B).  During the experiments, we also 
observed that the changes in anisotropy values consistently decreased during sequential 
replicate stopped-flow runs from the same pre-assembled +1 elongation complex 
mixture, and this effect was most pronounced with mutations to the smaller valine and 
alanine residues. Because the baseline fluorescence anisotropy signal is representative of 
the amount of RNA bound to polymerase and the amplitude of the signal change is 
dependent on the number of RNA molecules being elongated, these findings suggested 
that the mutations at Trp5 decreased the amount of active 3Dpol elongation complex in the 
reactions. 
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Table 3.2. Enzymatic parameters of 3Dpol elongation complexes. 














wild-type 8.6 ± 0.6 2.1 ± 0.1 18 ± 3 186 ± 4 
Trp5Tyr NDa ND ND 56 ± 3 
Trp5Phe 9.7 ± 2.4 1.8 ± 0.2 10 ± 3 26 ± 1 
Trp5Leu ND 1.9 ± 0.2 17 ± 3 4.4 ± 0.4 
Trp5Val 7.2 ± 0.5 3.0 ± 0.3 22 ± 7 5.3 ± 0.5 
Trp5Ala ND 2.0 ± 0.1 17 ± 2 5.3 ± 0.2 
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FIG. 3.4 D E. 3Dpol elongation stability. (A) Raw stopped-flow data showing the 
elongation curves of wild-type, Trp5Phe, and Trp5Ala 3Dpol at 40 µM NTPs. The 
difference in amplitude change and the decrease in starting baseline value 
indicates that there are fewer complexes being elongated for Trp5Phe and Trp5Ala 
mutants compared to the wild-type enzyme. (B) Expansion of Trp5Ala data from 
panel A illustrating that the signal for Trp5Ala retains the expected shape and an 














































3.2.4 Residue 5 mutations have significant effects on elongation complex stability 
To more specifically determine the effects of Trp5 mutations on elongation 
complex stability we designed an experiment, described in Chapter 2, Section 2.7, to first 
form stalled +2 elongation complexes and then measure, as a function of incubation time, 
how efficiently the +2 RNA could be elongated to the longer +20 product by the addition 
of the remaining NTPs. The 9+2-24 RNA was used to generate +2 complexes in the 
presence of ATP and GTP for 5-15 minutes (to reach >95% complex formation based on 
rates listed in Table 3.1) and the reactions were then diluted 10-fold with buffer 
containing either 300 mM NaCl or 75 mM NaCl.  The 10+1-12 RNA was also added at 
this point to serve as a degradation and reinitiation control. At various time points post-
dilution, small samples of the reaction were tested for their ability to rapidly incorporate 
additional nucleotides in 3 minutes and the products were analyzed by denaturing PAGE 
and quantitation of the IRdye labeled RNAs. 
As shown by the gels in Fig. 3.5A, wild-type 3Dpol forms a very stable elongation 
complex that efficiently chases the +2 RNA into +20 product even after several hours of 
incubation at room temperature in 300 mM NaCl.  The various Trp5 mutants, on the 
other hand, exhibited a rapid loss of elongation ability that ranked according to the size 
and hydrophobicity of the mutant residue; tyrosine and phenylalanine had the smallest 
effects (3 to 7-fold) while leucine, valine, and alanine reduced complex stability more 
than 35-fold.  Quantitation of the gel bands and plotting of the data as a fraction of the +2 
RNA that could be elongated, i.e. [+20 band] ÷ [sum of +2 and +20 bands], showed that 
the loss of competent elongation complexes exhibited single exponential decay behavior 
(Fig. 3.5B).  Curve fitting of the data revealed that the wild-type 3Dpol elongation 
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FIG. 3.5. Elongation complex stability. (A) Denaturing PAGE showing +2 ECs 
can be chased to +20 product after various incubation times. ECs were formed by 
the pre-incubation of 1 µM 9+2-24 PETE RNA, 15 µM 3Dpol, and 40 µM ATP and 
GTP to form the +2 elongation complex from the starting RNA [S], diluted 10x in 
300 mM NaCl and then chased at indicated times by addition of NTPs for 3 
minutes prior to quenching the samples. The stability is determined by calculating 
the fraction of RNA able to chase from the +2 band to the +20 band. (B) Plot of 
data obtained from PAGE analysis showing single exponential loss of 3Dpol 















































complex has a decay constant of about three hours; this is reduced to ≈55 and ≈25 
minutes for the Trp5Tyr and Trp5Phe mutants, and to as little as ≈5 minutes for the 
leucine, valine and alanine mutants (Table 3.2).  No elongation of the control RNA 10+1-
12 was observed, confirming that the +20 products arise only from the pre-formed 
elongation complexes. 
We did see evidence of RNA release and reinitiation during the incubation period 
when the elongation complexes were diluted in 75 mM NaCl without heparin (Fig. 6.3A), 
as opposed to 75 mM NaCl with heparin or 300 mM NaCl without heparin.  In this case 
the elongation complex decay curves showed biphasic characteristics, with a fast phase 
matching that seen in the presence of higher salt and a slow phase whose amplitude was 
dependent on the post-dilution protein concentration, as determined by changing the 
dilution factor between the complex formation and incubation steps from 2- to 5- to 10-
fold (Figs. 3.6 B and C).  We interpret this slow phase formation of the +20 product as 
being due to reinitiation on RNA that has been released during the extended incubation 
step. This suggests that the polymerase dissociates from the RNA upon inactivation, 
allowing the RNA to be rebound and elongated by another polymerase molecule. 
To verify that the mutant polymerases remained soluble during the elongation 
complex stability assays, we repeated the experiments and centrifuged the sample to 
pellet any precipitated protein and then analyzed the supernatant by SDS-PAGE, methods 
described in Chapter 2, Section 2.8. These experiments were performed on Trp5Tyr and 
Trp5Ala mutants and no loss of soluble 3Dpol was observed for either mutant with assay 
done at room temperature (Fig 3.7). However, we did observe loss of soluble protein in 
samples that were incubated at 37 °C (≈80% in 75 mM NaCl and ≈20% in 300 mM 
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FIG. 3.6. Salt effects on elongation complex stability. (A) Denaturing PAGE 
showing Trp5Phe +2 ECs chased to +20 product in 75 mM (left) or 300 mM 
(right) NaCl after various incubation times. (B) Data comparing stability of 
Trp5Phe elongation complexes in 75 mM and 300 mM NaCl. The 75 mM NaCl 
decay curve exhibits biphasic behavior. The first phase is indicative of EC stability 
and the second rate is protein concentration dependent and indicative of 3Dpol 
rebinding and reinitiating on released RNA. (C) Plot of Trp5Leu elongation 
complex stability in 75 mM NaCl after 2, 5, and 10-fold dilutions of the +2 
complex (resulting in 7.5, 3, and 1.5 µM final 3Dpol) to show that the second rate 
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FIG 3.7. Solubility of 3Dpol during stability assays. Assays were performed 
exactly as elongation complex stability assays but instead of chasing at indicated 
times 14 µl samples were removed, centrifuged and supernatant was analyzed by 
SDS-PAGE. (A) W5Y and (B) W5A stability at 75 mM (top) and 300 mM 
(bottom) NaCl. All samples indicate 3Dpol is able to stay soluble entirety of 
stability assays. Lane C, is an insoluble control made by incubating 3Dpol at 37oC 




NaCl), consistent with the ≈40 °C melting point of 3Dpol (151). These results indicate that 
the polymerase remains soluble throughout the stability assays done at room temperature. 
3.3 Discussion 
The crystal structures of the polio, coxsackie, rhino, and foot-and-mouth disease 
virus polymerases show a conserved structural motif whereby the very N-terminus of the 
protein is buried in a pocket at the base of the fingers domain.  This conformation is 
essential for polymerase activity and can only be formed after the proteolytic processing 
of 3CDpro to generate the native 3Dpol N-terminus.  When solving the structure of 
coxsackievirus B3 polymerase, we also noticed the structural conservation of a distortion 
in the β-strand composed of residues 1-9 that resulted in the usually hydrophobic residue 
5 being exposed on the surface of the protein (Fig. 3.1A) (32). Through mutational 
analysis we found that residue 5 was indeed important for coxsackievirus 3Dpol function; 
mutations of the native phenylalanine to smaller residues greatly decreased polymerase 
activity while mutation to a larger tryptophan increased polymerase activity as 
determined by product formation in a poly-A template activity assay. The 3Dpol structures 
lead us to propose that residue 5 could flip into an adjacent hydrophobic pocket during 
the catalytic cycle, providing a driving force for NTP positioning prior to catalysis. 
In this work we further elucidate the function of residue 5 and the role it plays in 
the molecular mechanisms of 3Dpol initiation and elongation.  Formation of an active 
3Dpol elongation complex is a multi-step process that has been well characterized for 
poliovirus (9) and foot-and-mouth disease virus (6) polymerases.  Overall, the process 
consists of a) RNA binding followed by an initial conformational change to generate a 
catalytically competent complex, b) a second conformational change associated with 
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incorporation of the first NTP to generate the elongation complex, and c) processive 
replication of the entire viral genome.  Mutations at residue 5 could affect 3D
pol
 activity 
by altering the initiation steps, by altering the elongation rate of the enzyme, or by 
altering the stability of the elongation complex. 
To determine if residue 5 was involved in initial RNA binding we utilized a 
solution based fluorescence polarization assay to measure the affinity of a short hairpin 
RNA in 75 mM NaCl (99). The data collected from mutations that introduce either a 
planar phenylalanine or a smaller branched valine showed no significant effects on RNA 
affinity as compared to the wild-type enzyme, indicating that 3Dpol residue 5 is not 
involved in RNA binding in the absence of nucleotides. To assess initiation and 
elongation complex formation we used two different length hairpin RNA substrates in the 
same reaction to simultaneously measure +1 product formation due to guanosine addition 
and +2 product formation due to adenosine and then guanosine addition. The RNAs were 
designed such that the resulting +1 and +2 complexes had exactly the same RNA 
sequence in the vicinity of the active site and differed only in the length of the remaining 
single stranded template sequence (Fig. 3.1B). The results show that all the Trp5 
mutations slowed the rate of elongation complex formation, with smaller residues having 
slower complex formation rates (Fig. 3.2), but the effect of the mutations on the 
formation rate were at most only ≈3-fold (Table 3.1).  While statistically significant, 
these changes in rate are not sufficient to be the sole contributor to the changes in activity 
we previously observed for the analogous mutations in coxsackievirus 3Dpol (32). 
 Using our PETE assay in a stopped-flow kinetic format (59), we also established 
that the mutations at Trp5 do not affect 3Dpol elongation rates, with all the mutations 
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having Vmax and apparent NTP Km values comparable to that of the wild-type enzyme 
(Fig. 3.3 & Table 3.2).  We saw evidence during these elongation experiments that 
suggested residue 5 was involved in maintaining a stable elongation complex (Fig. 3.4).  
To show that residue 5 mutations have significant effects on the temporal stability of the 
competent 3Dpol elongation complex we designed an assay where the initial elongation 
complex is stalled after formation of the +2 product by omitting the next nucleotide 
triphosphate, and the ability of these stalled complexes to rapidly elongate the RNA by 
another 18 nucleotides was tested as a function of incubation time (Fig. 3.5). 
 Wild-type 3Dpol elongation complexes are quite stable and exhibit mono-
exponential decay with a time constant of about three hours.  The Trp5 mutations, on the 
other hand, show very rapid loss of elongation ability, with decay time constants of ≈55 
and ≈25 minutes for tyrosine and phenylalanine mutants respectively, and only 5-15 
minutes for the smaller leucine, valine, and alanine mutants (Table 3.2).  All the proteins 
show mono-exponential loss of elongation ability in 300 mM NaCl or in 75 mM NaCl in 
the presence of heparin. However, in 75 mM NaCl without heparin we observe a biphasic 
decay curve whose second phase is dependent on protein concentration (Fig. 3.6C).  This 
latter observation indicates that the loss of elongation complex competency is associated 
with a release of the RNA from the polymerase, allowing it to be rebound by another 
3Dpol molecule for reinitiation in a secondary reaction whose rate is 3Dpol concentration 
dependent.  Furthermore, the elongation complexes are slightly more stable in 300 mM 
than in 75 mM NaCl (Fig 3.6B); suggesting that maintaining the proper conformation of 
the complex may involve hydrophobic interactions that would be favored at the higher 
salt concentrations.  
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While our results show that residue 5 is important for the stability of the 
elongation complex, the molecular and structural details underlying this stabilization are 
not yet known. It may be that residue 5 interacts directly with the RNA template via base 
stacking interactions that are likely to be disrupted by mutations to small and non-planar 
amino acids, as shown by our data. While this could be the case for poliovirus and 
coxsackievirus polymerases that have tryptophan and phenylalanine residues at position 
5, it is less likely for the structurally homologous rhinovirus enzyme having a small 
hydrophobic residue and foot-and-mount disease virus 3D
pol
 where residue 5 is an 
aspartic acid. Alternatively, residue 5 may play a role in maintaining 3D
pol
 in the proper 
conformation for processive elongation. For example, residue 5 could move into the 
hydrophobic pocket of the fingers domain as we suggested when describing the 
coxsackievirus 3D
pol
 structure (32); however, based on the new data resulting from this 
work we now expect this structural rearrangement to occur only once during elongation 
complex formation, fixing the hydrophobic residue within the nearby pocket rather than 
reiteratively flipping in and out of the pocket with each cycle of nucleotide addition. 
Notably, structures of 3D
pol
–RNA complexes from the homologous foot-and-mouth 
disease virus and Norwalk virus polymerases (53, 54, 163), as well as the PV 3Dpol 
elongation complex (60), indicate that residue 5 remains solvent exposed, suggesting that 
a structural rearrangement involving residue 5 may not occur. However, the RNA 
templates in the foot-and-mouth disease and Norwalk virus structures are not long 
enough to reveal whether or not the template strand interacts directly with the polymerase 
in the vicinity of residue 5 and the PV 3Dpol-RNA elongation complex template is 
hindered by the crystal packing lattice (60). Thus, amino acid residue 5 could still 
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participate in structural rearrangements, interactions with template RNA or has some 
other function that we have yet to consider. 
In conclusion, we have used poliovirus polymerase to further dissect the 
importance of residue 5 for 3Dpol function by generating a series of point mutations and 
measuring their effects on RNA binding, elongation complex formation, elongation rate, 
and the temporal stability of the elongation complex.  The data show that while residue 5 
plays a small role in elongation complex formation, the mutations have no effect on the 
elongation rate of the enzyme, and instead have significant effects on the stability of the 
elongation complex.  These results indicate that the size and hydrophobicity of residue 5 
are important for maintaining the 3D
pol







The Impact of Elongation Complex (In)Stability on Genome Replication 
4.1 Introduction 
 This chapter has been published as part of:  Hobdey, S.E., Kempf, B.J., Steil, B.P., 
Barton, D.J., and Peersen, O.B. (2010) J Virol 84,8072-8084. 
 Authors contributing to this chapter:  Hobdey, Figs 4.1 to 4.7 with Fig. 4.7 under 
the supervision of author Steil; Kempf, Figs 4.8 and 4.9 and Table 4.1. Authors Steil and 
Kempf were members of the Barton laboratory at the University of Colorado Health 
Sciences Center in Aurora, CO. 
 In Chapter 3 we discussed the effects PV 3Dpol residue 5 on the in vitro stability 
of stalled elongation complexes (ECs). In this chapter I will discuss the significance of 
EC stability on viral genome replication. Cell-free replication was completed by me 
under the instruction of Ben Steil in David Barton’s laboratory at the University of 
Colorado’s Health Sciences Center in Aurora, CO.  For the infectious virus experiments I 
generated the 3Dpol cDNA mutations and sent plasmids to Brian Kempf of the Barton lab 
who carried out the infectious virus studies. 
 The formation of the picornavirus EC, 3Dpol-RNA-NMP, is a rate limiting step in 
RNA replication that is required for the initiation of RNA replication initiation (7, 9, 11). 
This complex with the poliovirus (PV) wild-type 3Dpol has been shown to be very stable 
(9). As shown in Chapter 3, mutations to residue 5 of the PV 3Dpol have significant 
effects on EC stability; however, the significance of EC stability in viral replication was 
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not discussed. We hypothesized that an unstable EC would have significant effects on 
elongation with longer RNA templates; specifically, that the polymerase may fall off the 
RNA template during replication thus reducing polymerase processivity. 
  Polymerase processivity is defined as the average number of nucleotides 
incorporated into a primer before dissociation from the template. Processivity has been 
studied extensively for both RNA and DNA polymerases (76, 147). Highly processive 
DNA polymerases commonly require accessory proteins for processive DNA replication. 
For example, DNA polymerase III requires a sliding clamp that binds to the DNA 
polymerase and forms a ring-shaped structure around the DNA template to prevent 
polymerase dissociation (144, 145). The T7 bacteriophage DNA polymerase is controlled 
by an entirely different mechanism where the T7 polymerase has relatively low 
processivity alone, but it recruits the host protein thioredoxin to increase processivity 
about 80-fold by increasing the half-life of the DNA-polymerase complex from 1 second 
to 5 minutes (75, 76, 97, 146). Thioredoxin is an enzyme responsible for multiple redox 
reactions, including reduction of the ribonucleotide reductase, the enzyme required for 
the formation of DNA from RNA precursors (74). Thioredoxin has no DNA binding 
properties except when in complex with the T7 DNA polymerase (8). RNA polymerases, 
e.g. T7 RNA polymerase, have been found to be extremely processive as monomer (102) 
and affects to processivity have been found via point mutations within the polymerase 
protein itself (91). Interestingly, in all cases any change to polymerase processivity has 
been directly related to increasing or decreasing the polymerase-RNA dissociation 
constant (Kd) or RNA replication rate (74, 91, 145). Recently, a clamp-like structure has 
been found for the PV 3Dpol where the pinky and thumb of 3Dpol insert into the major and 
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minor groove, respectively, of the upstream dsRNA (60). However, it is not known if this 
clamp is required for processivity or affects the Kd of the polymerase-RNA complex. 
 Previous reports have shown that the PV 3Dpol is a highly processive polymerase 
with ~1 initiation event per genome replication (134); however, these experiments were 
completed on ~1.5 kb templates and only elongation products < 800 nucleotides were 
resolved, thus abortive products longer than 800 nucleotides would not have been 
observed (134). In this same report the authors did show that the Kd for the 3Dpol-RNA 
complex and processivity of 3Dpol can be modulated independently, whereby the 
presence of PV protein 3AB decreased the 3Dpol-RNA Kd but had no effect on 3Dpol 
processivity.  
 Here we used PV sub-genomic RNA (Fig. 4.1A) to show that residue 5 of the PV 
3Dpol has significant effects on polymerase processivity. These mutations have negligible 
effects on Kd but have significant effects on EC stability (Table 3.2, Chapter 3). Also, we 
show that processivity plays a signification role in RNA replication in the context of viral 
replication centers via cell-free coupled translation-replication reactions; and furthermore 
affect virus propagation at the cellular level. Furthermore, we found that the 5’NTR, an 
element with extensive RNA structure (Fig 4.1D), has significant effects on 3Dpol 
processivity, especially for the residue 5 mutants. 
4.2 Results 
4.2.1 PV 3Dpol Residue 5 mutants affect replication processivity 
Elongation processivity was determined by monitoring the amount of abortive 
products generated during replication of longer genomic RNAs by 3Dpol. Poliovirus RNA 
templates were generated by T7 transcription from linearized pRNA2, resulting in 2201 
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FIG. 4.1. Poliovirus RNA genome used for processivity experiments.  
(A) Genomic RNA 5’ UTR (non-translated region) with cloverleaf and IRES 
(internal ribosome entry site) RNA secondary structures.  Followed by the ORF, 
missing the capsid domain, and 3’ NTR. Bars indicated cut sites by restriction 
enzymes: SpeI, 2201 nt; AvrII, 5424 nt; MluI, 5742 nt. (B) RNA template used in 
primer extension assays. DNA primers are purple arrows. (C) Self-priming RNA. 
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81
or 5424 nucleotide long RNA templates (Fig 4.1). These pRNA2 templated T7 
transcription reactions also produced an additional 670 nucleotide fragment that 
corresponds to most of the poliovirus 5’ NTR, including the IRES.  This smaller fragment 
is due to the presence of a T7 polymerase abortive sequence, 5’-UAUCUGUU-3’ (96), 
found shortly after the IRES element in the pRNA2 cDNA.  This fragment is present in 
all the 3Dpol elongation reactions and provides additional elongation data from a shorter 
RNA template that is rich in structure. 
 Primer extension - My first attempt to characterize elongation processivity 
employed a primer extension assay by annealing an IRdye labeled DNA primer to a sub-
genomic length RNA template replication, described in Chapter 2, Section 2.9.1.  Primers 
were designed to anneal to the first CUCUn sequence after the linearization so that a 
locked elongation complex could be generated then chased. This required that the SpeI 
primer be 161 nts upstream of the SpeI linearization site while the AvrII primer annealed 
right at the linearization site (Fig. 4.1B). Experiments for agarose gel analysis were 
performed by annealing DNA primer to RNA template (see Materials and Methods in 
Chapter 2, section 2.7.1)  then incubating 0.4 µM RNA/primer substrate, 10 µM 3Dpol an 
40 µM each NTP in our standard 75 mM NaCl buffer. Pre-incubation for elongation 
complex formation step was omitted in this particular experiment. Experiments for PAGE 
analysis were performed by annealing the DNA primer to the RNA template then 
incubating 0.25 µM RNA/primer substrate with 20 µM 3Dpol and 500 µM each CTP and 
UTP for elongation complex formation, in 75 mM NaCl, 2.5 mM MgCl2 and 50 mM 
HEPES pH 6.5. After 40 minutes of room temperature incubation, the reaction was 
diluted 5-fold into a high salt buffer containing all NTPs to a final concentration of 120 
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µM. The extended DNA primer was run on a non-denaturing agarose gel or denaturing 
PAGE to determine the elongation efficiency (Fig. 4.2). These experiments showed that 
the annealing (AvrII) or elongation (SpeI and AvrII) efficiency of the DNA primer to the 
RNA was low (Fig. 4.2A). Interestingly, the agarose gel shows that the presence of non-
elongated, unannealed primer increased after elongation of the 2201 nt template, 
suggesting that the primer is being displaced during elongation. This effect was not so 
significant for the AvrII primer/template pair which annealed at the very 3’ end of the 
template. The PAGE analysis of elongation of the AvrII template shows expected 
elongation at early time points with primer laddering indicating single nucleotide 
incorporations and later time points show accumulation of larger products near the well 
(Fig. 4.2B). Attempts to repeat this experiment were unsuccessful.  Figure 4.3 shows the 
IR and UV image of an elongation experiment of SpeI primer/RNA. The experiment was 
performed as described above and images show the differences between the IR-dye 
labeled primer and the total RNA population. The annealed primer is displaced from the 
RNA template as during elongation and very little primer extension can be seen.  The UV 
image indicates that more RNA is being elongated than is seen in the IR image and shows 
that the IRES element (the 5’ 660 nts) is able to self-prime and be elongated.  
Self-priming extension - To initiate RNA elongation we utilized the fact that the 
3’ ends of single stranded RNA transcripts often form localized snap-back structures that 
create self-priming hairpins for RNA elongation by 3Dpol (35). Experiments were 
performed by pre-incubating 0.4 µM RNA, 20 µM polymerase and 500 µM each of all 
four NTPs for 7-15 minutes at room temperature to form elongation complexes, 
mimicking the locked complex formation step used in the polymerase rate and stability 
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FIG. 4.2. DNA primer extension assay. (A) Infrared image of agarose gel 
showing annealing and elongation efficiency of SpeI primer on the 2201 nt 
template (left) and AvrII primer on 5424 nt template (right). Primers were 
annealed by heating 75 µM RNA template and primer in 16 mM NaCl 1.6 mM 
MgCl2 at pH 7.5 to 90oC and slow cooling, 1 degree every 3 minutes to 30oC. 
Annealed RNA primers were extended by the incubation 0.25 µM template RNA, 
100 µM each NTP and 4.0 µM 3Dpol in 75 mM NaCl and 2.5 mM MgCl2. 
Elongation reactions were incubated for 20 min at room temperature. (B) 
Denaturing PAGE showing a time-course of AvrII primer extension. Lane P 
indicates control with no RNA template. 
A B AvrII 5424  nt template 
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FIG. 4.3. Discovery of RNA self-priming. (A) Infrared image of agarose gel 
showing annealing and elongation of SpeI primer on the 2201 nt template (left) 
and UV image of EtBr stain of same gel (right). Lanes 1 and 2 represent + or – 
3Dpol respectively.  IR-image shows only primer populations where increase in 
non-elongated, unannealed primer in lane 2 indicates the annealed primer (lane 1) 
is being displaced by the polymerase during elongation. The IRES element from 
the IR-image is likely due to non-specific interactions or primer trapping. The UV-
image shows total RNA population including a larger RNA population that has not 
been extended from the primer (self-priming elongation). Also, elongation of the 
IRES element shows capability of self-priming. (B) Schematic of primer 
displacement by elongation (right) from 3’ hairpin. DNA primer represented by 























assays.  After this pre-incubation step, the complexes were diluted into high salt to 
prevent polymerase rebinding and additional initiation events during the elongation phase 
of the experiment, methods described in Chapter 2, Section 2.9.2.  At indicated time 
points, reaction samples were quenched, phenol-chloroform extracted, and RNA content 
was analyzed by nondenaturing agarose gels stained with ethidium bromide.  
Elongation of the 2201 (Fig. 4.4, top) and 5424 (Fig. 4.4, bottom) nucleotide long 
templates showed that the amount of full-length duplex RNA synthesized by 3Dpol was 
slightly reduced for the tyrosine and phenylalanine mutants as compared to the wild-type, 
and significantly reduced with the leucine, valine and alanine mutants. The elongation 
rate of wild-type and mutant polymerases was calculated to be ~0.4 nt/sec based on the 
≈90 minutes needed to elongate the 2201 nt template. This is ≈5-fold slower than the 
rates observed in the PETE assay (Table 3.2, Chapter 3) and could be due to an increase 
in the NTP Km
app due to the increased salt concentration during the elongation phase. In 
addition to a clear band that reflects full-length duplex RNA, the reactions with wild-type 
3Dpol also show the time-dependent accumulation of very large and heterogeneous RNA 
products just below the sample wells.  The amount of these large RNA products is 
reduced when Trp5 is mutated to phenylalanine or tyrosine and largely eliminated with 
the smaller leucine, valine, and alanine mutants (Fig. 4.5). 
Elongation from self-primed templates also resulted in intermediate length RNA 
bands. Some of these RNAs continue to be elongated, suggesting there may be sites 
where the polymerase pauses, while other bands are no longer being elongated, indicating 
they are abortive products. Figure 4.5 shows a side-by-side comparison of products 
formed by wild-type and residue 5 mutant polymerases after 120 minutes of elongation 
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FIG. 4.4. Elongation processivity of self-primed poliovirus RNA. Ethidium 
bromide stained nondenaturing agarose gel electrophoresis showing a time course 
analysis of RNA elongation through (A) 2201 nt template and (B) 5424 nt 
template. RNA transcripts were pre-incubated with 20 µM 3Dpol, 0.4 µM RNA 
and 0.5 mM NTPs in 75 mM NaCl for 7, 10 or 15 minutes to allow for initiation 
and the reactions were then diluted 5-fold into 300 mM NaCl and 260 µM NTPs. 
Reactions were quenched at indicated times. The IRES (internal ribosome entry 
site) band is from a T7 abortive sequence located just after the IRES in the 




FIG. 4.5. Comparison of processivity from residue 5 mutants.  Ethidium 
bromide stain of nondenaturing agarose gel electrophoresis directly comparing 
elongation of the 2201 nt RNA template by the different mutant polymerases after 
120 minute reaction time. 
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on the 2201 nt template.  The data show that wild-type 3Dpol produces few abortive 
products, the tyrosine mutant produced slightly more abortive products, and the leucine, 
valine and alanine mutants result in significantly more abortive products.  For these 
smaller mutations, the abortive products represent a significant fraction of the final 
material when one considers that template utilization is also reduced by less efficient 
initiation. 
The 670-nucleotide band resulting from the T7 abortive sequence in the 5’NTR is 
composed almost entirely of the internal ribosome entry site (IRES). This transcript can 
also self-prime and be elongated by the polymerase, albeit with reduced efficiency for the 
residue 5 mutants compared to wild-type. Interestingly, the alanine, valine and most of 
the leucine mutant never reach the 5’ end of this short template.  Although gels in Figure 
4.4 and 4.5 do not have the resolution to show abortive products for the IRES band, it is 
apparent by the amount of elongation product that the mutant polymerases were 
extremely inhibited in replication of the IRES, and more so than for the full-length RNA 
elongation.  These data suggest that replication through extensive RNA structure is more 
difficult for residue 5 mutants than for wild-type 3Dpol, significantly slowing the 
polymerase and giving the unstable mutant polymerases time to dissociate from the 
template RNA.  Consistent with this, the longer sub-genomic products generated by the 
mutants appear slightly shorter than those from the wild-type enzyme (Fig. 4.5), 
suggesting the mutants may not have replicated through the IRES that would be at the 
end of the negative-strand template. 
When the 5’ NTR, including the IRES element, was removed from the 5242 nt 
RNA template the processivity increased for all polymerases, but the efficiency of RNA 
89
elongation was still lower for the mutants (Fig.4.6), indicating that downstream RNA 
structure may be having distant affects polymerase elongation. For wild-type and the 
Trp5Tyr mutant polymerase, two RNA populations can be seen with a lighter RNA band 
that runs about 1 kb above a more definite RNA product. The stronger band was the RNA 
product that was seen for all polymerase elongation reactions. Also, after removal of the 
5’NTR there are less large RNA products that remained in the well when compared to 
replication of RNA with the 5’ NTR (compare wells from Fig. 4.5 to Fig.4.6). The time 
course shows that there was no effect on elongation rate in the absence of the 5’ NTR, 
where the 4339 nt template was replicated in ~180 minutes, or ~0.4 nt/sec. 
4.2.2 Processivity effects caused by residue 5 mutations result in decreased RNA 
synthesis in a cell-free replication system 
To ascertain the effects on the Trp5 mutations on viral genome synthesis we 
carried out cell-free coupled translation-replication reactions, described in Chapter 2, 
Section 2.10. Negative-strand RNA synthesis from sub-genomic poliovirus replicons 
harboring wild-type and Trp5Phe 3Dpol showed replication to the full-length negative-
strand within 60 minutes, but the phenylalanine mutant had significantly lower yield than 
wild-type (Fig. 4.7A). Negative-strand RNA synthesis by the Trp5Ala mutant replicon 
was too faint to be detected after 60 minutes of replication, but a small amount of full-
length negative-strand RNA product could be detected after 120 minutes of replication. 
In a time course experiment with wild-type and Trp5Phe 3Dpol we see that the two 
polymerases replicated poliovirus RNA at similar rates as both reached their maximal 
yield of negative-strand RNA after ≈45 minutes of incubation, but the Trp5Phe mutant 
yielded much less negative-strand RNA product (Fig. 4.7B). The reduced synthesis of 
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FIG. 4.6. Elongation processivity minus the 5’ NTR. Ethidium bromide stained 
nondenaturing agarose gel electrophoresis showing a time course analysis of RNA 
elongation through a 4339 nt template with wild-type, Trp5Tyr (A) Trp5Leu and 
Trp5Ala (B). RNA transcripts were pre-incubated with 20 µM 3Dpol, 0.4 µM RNA 
and 0.5 mM NTPs in 75 mM NaCl for 7, 10 or 15 minutes to allow for initiation 
and the reactions were then diluted 5-fold into 300 mM NaCl and 260 µM NTPs. 
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FIG. 4.7. Negative-strand RNA synthesis in a cell-free translation-replication 
system. (A) Endpoint analysis showing amounts of full-length negative-strand 
RNA produced by replicons containing wild-type, Trp5Phe (50% of wild-type) in 
60 minutes. Product from the Trp5Ala (10% of wild-type) mutant was barely 
detectable after 120 minutes of replication. (B) Time course of product formation 
showing that both wild-type and Trp5Phe 3Dpol reach maximum RNA quantities 
after ≈45 minutes of replication, indicating that the polymerase mutations affect 




negative-strand RNA by Trp5Phe and Trp5Ala mutants is likely due to instability of the 
elongation complexes as a result of the residue 5 mutations. Importantly, these results 
indicate that in authentic RNA replication complexes the mutations to residue 5 do not 
affect the elongation rate itself, but rather the amount of full-length viral RNA produced. 
4.2.3 A processive polymerase is required for viral propagation 
 To test the ability of the polymerase mutants to support virus growth we 
transfected HeLa cells with positive-strand genomic RNA containing the Trp5Phe and 
Trp5Leu mutations, described in Chapter 2, Section 2.11. Both mutants produced 
infectious virus (Table 4.1) and at 48 hours post transfection (hpt) the Trp5Phe mutant 
had only slightly lower viral titer than wild-type (6.4x106 vs. 2.5x107 PFU/ml) while the 
Trp5Leu viral titer was significantly lower at 1.7x104 PFU/ml.  After 72 hours the titers 
of wild-type and Trp5Phe viruses were essentially equivalent at ~5.0x107 PFU/ml, 
although the phenylalanine mutant produced slightly smaller plaques (Fig. 4.8A). 
Sequencing confirmed that the Trp5Phe mutation was stable in the progeny virus 
population.  Growth of the slow Trp5Leu virus, on the other hand, improved dramatically 
between 48 and 72 hours, producing plaques similar to the wild-type virus that suggested 
a reversion or acquisition of some compensatory mutation. This was confirmed by 
sequence analysis of the 3Dpol gene from progeny virus showing a mixed population of 
Leu5 and Trp5 residues at 48 hpt and complete reversion of the virus population to wild-
type tryptophan at 72 hpt (Fig. 4.8B). 
One-step growth curves of wild-type and the Trp5Phe 3Dpol mutant were 
performed by infection of HeLa cells (~106 cells per 35 mm well) with a multiplicity of 
infection (MOI) of 10 viruses per cell, described in Chapter 2, Section 2.12. 1 hour after 
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* Individual cDNA clones were sequenced. 13 out of 22 (59.1%) cDNA clones had a 
leucine (CUA) codon and 9 out of 22 (40.9%) cDNA clones had a tryptophan (UGG) 
codon. 
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A 
FIG. 4.8. Viability of poliovirus engineered to express residue 5 mutations. (A) 
Representative plaques from wild-type poliovirus and poliovirus with 3Dpol 
Trp5Phe mutation. (B) Sequence data of Trp5Leu cDNA PCR products from 
poliovirus at 48 hpt (left) and representative sequence data from individual cDNA 
clones (right). 
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adsorption virus inoculum was removed and replaced with 2 ml of culture medium and 
incubated at 37oC for 1, 2, 3, 4, 6, 8 and 24 hours post-adsorption (hpa) before 
undergoing 3 freeze-thaw cycles to release virus. Growth curves were plotted as virus 
titer from plaque assays versus time (Fig. 4.9). In agreement with the prior transfection 
and plaque assay data, Trp5Phe 3Dpol produced viable virus with a growth rate that was 
only slightly slower than the wild-type virus and it reached the same end point of 
~5.0x109 PFU/ml at 24 hpa. 
4.3 Discussion 
PV 3Dpol residue 5 mutations have previously been shown to have significant 
effects on elongation complex stability, where there is a requirement for a large 
hydrophobic residue at this position to maintain a stable complex. Here we investigated 
the significance of a stable elongation complex in the context of genome replication. To 
do this we studied the ability of residue 5 mutations to replicate long, sub-genomic, PV 
RNA templates; as well as their ability to replicate in the cell-free system and in full 
virus. We found that mutations to residue 5 that reduced the elongation complex stability 
also had a significant reduction in polymerase processivity, or the number of nucleotides 
incorporated before dissociation. Also, the effects can be seen in the context of the cell-
free replication where less RNA is generated from replication centers and in the full virus 
where severe processivity mutants were unable to maintain viral propagation. 
My early attempts to study the ability of reside 5 mutations to replicate sub-
genomic length PV RNA were unsuccessful due to inefficient substrate binding and 
elongation. The experimental design was to monitor primer extension from an IRdye 
labeled DNA primer annealed to a sub-genomic RNA template (Fig. 4.1B). Results 
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FIG. 4.9. One-step growth curve of wild-type and Trp5Phe poliovirus. HeLa 
cells (~106 cells per 35 mm well) were infected with 10 PFU per cell of wild-type 
or Trp5Phe poliovirus. After adsorption for 1 hour at room temperature, the virus 
inoculum was removed, the cells were given 2 ml of culture medium and 
incubated at 37°C. Cells were subjected to 3 cycles of freeze-thaw at 0,1,2,3,4,6,8 
and 24 hours post-adsorption (hpa). Poliovirus titers were determined by plaque 
assay and plotted versus time. 
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showed that replication efficiency was low; it was difficult to get good resolution from 
long primer extensions (Fig. 4.2), and when I did see decent separation (Fig. 4.2B) the 
experiment was very difficult to repeat. However, displacement of the DNA primer 
during these experiments suggested that there was priming upstream of the oligo, 
possibly because the 3’ end of the primed RNA template was folding back on itself to 
provide an RNA hairpin primer that was suitable for elongation (Fig. 4.3). We utilized 
this self-priming hairpin to carry out the rest of our sub-genomic length RNA replications 
(Fig 4.1C). 
We found that the decreased elongation complex stability also reduced 
polymerase processivity during replication of longer RNA templates. Elongation of self-
primed 2201 and 5424 nt RNA templates showed that mutation of Trp5 to smaller 
residues resulted in the accumulation of abortive intermediate length products and very 
little full-length product. These effects were dependent upon the mutation, with the 
smaller valine and alanine mutants having the most deleterious effects (Fig. 4.5). The 
mutants also showed a decrease in template utilization that is attributed to their reduced 
elongation complex formation rates (Table 3.1, Chapter 3).  The abortive product bands, 
on the other hand, are attributed to elongation complexes that began during the low salt 
initiation step but failed to replicate to the very end of the template. These data indicate 
that the elongation complex stability is not only a characteristic of a stalled polymerase, 
but also of an actively elongating polymerase. The difference in processivity between the 
wild-type and mutant polymerases is also apparent from the amount of very large RNA 
produced in the reactions after long incubation times (Figure 4.4).  The composition of 
these large RNAs was not determined, but they are presumably due to some form of 
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template switching or internal re-annealing during the elongation reactions. The lack of 
distinct initiation events during the elongation step of these reactions was confirmed by 
control reactions that did not show any observable product formation under high salt 
conditions. 
The abortive products generated by the mutant polymerases also show several 
distinct bands that are suggestive of specific pause or dissociation sites along the 
template. Even the wild-type polymerase produces some abortive bands, something that 
has not been previously observed in studies showing that 3Dpol is quite processive and 
fully capable of elongation through secondary structures in the template (35). These 
bands are likely a result of our experimental conditions during the elongation phase of the 
reaction, where room temperature and high salt concentrations both act to stabilize RNA 
structures.  RNA structures may be able to inhibit or stall polymerase movement along 
the template, allowing less stable polymerases to dissociate from the RNA template while 
more processive polymerases eventually elongate through the duplex section.  In such a 
context, the increased banding seen with the smaller Trp5 mutants suggests that reduced 
elongation complex stability may be a particularly prominent defect when elongating 
through templates with double-stranded RNA structures.  This is also consistent with how 
inefficiently these mutants replicate the separate 5’ IRES fragment that is rich in RNA 
structure (Fig. 4.5).  In contrast, the tyrosine mutant and wild-type 3Dpol containing a 
tryptophan at residue 5 produce few distinct abortive product bands and they elongated 
through the IRES template without difficulty. These results indicate that large 
hydrophobic amino acids at residue 5 may increase processivity by facilitating the 
unwinding of dsRNA structures in poliovirus RNA templates. 
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Interestingly, when the 5’ NTR, including cloverleaf and IRES elements, was 
removed from the 5424 nt RNA template, the processivity increased for all polymerases 
(Fig. 4.6). This suggests that residue 5 mutants are significantly affected by RNA 
structures that are thousands of nucleotides downstream. It has been shown that the PV 5’ 
NTR cloverleaf and IRES element are required for genome replication (104, 156); 
however, these assays were completed in the cell-free replication system where it is not 
clear whether host or other viral proteins could be binding the 5’ NTR to aid in RNA 
replication or if the 5’ NTR is involved in specific RNA-RNA interaction. However, 
direct RNA-RNA interactions of other virus genomes have been shown in the absence of 
other virus and host proteins (4, 37). In these reports the 5’ and 3’ NTRs come together to 
circularize the RNA genome and this circularization is required for negative-strand RNA 
synthesis (4, 37). It could be that the PV genome has similar direct RNA-RNA 
interactions in the reactions performed here, and removal of the 5’ NTR prevents these 
interactions. In such case the interaction could cause disruption of the elongating 
polymerase so that instable polymerases abort the RNA template while more stable 
polymerase are able plow through and complete genome replication. Then removal of the 
5’NTR would allow more processive elongation from both stable and especially unstable 
polymerases. This idea is supported by the absence of the very large RNA products in the 
well when the 5’NTR is removed (compare wells in Fig. 4.4 and Fig. 4.6), where internal 
re-annealing could possibly be enhanced by a 5’NTR interaction with downstream RNA 
resulting in the formation of seemingly large RNA products. 
The two RNA products generated by wild-type and Trp5Tyr polymerases (Fig. 
4.6) are likely from two different priming sites caused by the non-specific fold-back and 
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are only visible for the polymerases that are able to make more stable ECs, Chapter 3 
(Table 3.2 ). Conveniently, the increase in processivity coupled with the secondary 
priming shows that the downstream 5’NTR only affects processivity and has little to no 
effect on EC stability; however, a more detailed study would be required to determine 
actual effects of downstream RNA structure on the EC decay constant. 
The effects of reduced elongation complex stability are also observed when the 
mutant polymerases are introduced into viral replication complexes using cell-free 
translation-replication reactions.  The poliovirus cell-free replication system was used to 
compare negative-strand RNA synthesis by wild-type and mutant polymerase (Fig. 4.7). 
This system depends on cis-active elements within native viral RNA templates (25, 103) 
and reveals biochemical defects in RNA replication associated with mutations in 3Dpol 
(22). In these reactions, 3Dpol mutations result in detectable synthesis of full-length 
negative-strand RNA product at a timescale comparable to that observed for the wild-
type enzyme, consistent with our biochemical finding that 3Dpol elongation rates are not 
affected by these mutations.  However, the amount of full-length negative-strand product 
produced is significantly reduced, consistent with the reduced initiation rates of the 
mutant polymerases and the formation of unstable elongation complexes that dissociate 
prior to reaching the end of the ≈6 kb replicon genome. 
Introduction of both the Trp5Phe and Trp5Leu 3Dpol mutations into poliovirus 
genomes resulted in virus growth after transfection into host cells. The phenylalanine 
mutation was stably maintained in the progeny virus with a slightly reduced plaque size 
but an essentially wild-type growth rate in a single step growth curve (Fig 4.9).  In 
contrast, virus containing the more deleterious leucine mutant grew very slowly with 
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titers at 48 hpt that were ≈1000-fold less than those of the wild-type virus.  The leucine 
mutation was not stable and sequencing of the progeny virus pool revealed a mixed 
population of leucine and tryptophan at residue 5 after 48 hours and completes reversion 
to the wild-type tryptophan by 72 hours post transfection (Table 4.1 and Fig. 4.8B). The 
loss of the leucine codon is not unexpected given the instability of its elongation 
complexes on the PETE RNAs and its inefficient synthesis of genomic size RNA in vitro, 
but it is a bit surprising that only a triple mutation (CUA to UGG) reversion to the wild-
type tryptophan was observed, rather than two mutations to generate a phenylalanine 
(CUA to UUU/C) that has essentially wild-type growth characteristics. These results 
demonstrate that poliovirus propagation is dependent upon processive RNA replication 
and that poliovirus 3Dpol can tolerate a small decrease in elongation complex stability and 
processivity and maintain the ability to propagate. The emergence of the Leu5Trp 
reversion and the genetic stability of the Phe5 mutant may also point to a requirement for 
a planar residue 5 in order to get optimal viral growth. 
In conclusion, we further dissected the importance of PV 3Dpol residue 5 function 
in context of genome replication by measuring the effect of residue 5 mutations in 
processivity. The results indicate that the size and hydrophobicity, and possibly the 
planarity, of residue 5 are important to maintain the 3Dpol in an elongation-competent 
state. Consistent with this, viral genomes containing Trp5 3Dpol mutations show reduced 
levels of RNA synthesis in cell-free translation-replication reactions and impaired growth 
of infectious virus that results in the rapid emergence of revertant virus. Interestingly, 
downstream RNA structure, such as the IRES, enhanced the processivity defects seen 
with the mutant polymerases in a reconstituted replication system; however, we were 
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unable to study these effects in the cell-free system or in vivo due to the requirement of 





Poliovirus 3Dpol Downstream RNA Interactions and Elongation Complex Lock 
Length 
5.1 Introduction 
 My work in this chapter is currently being written for journal publication. 
Authorship from publication of this chapter will included Hobdey, SE and Peersen, OB.  
 The poliovirus (PV) genome is comprised of a single strand of positive-sense 
RNA whose replication is dependent upon regions of higher RNA structure (160). In 
order for the virus to multiply in the host cell, numerous copies of the viral genome must 
be generated by the virally encoded RNA dependent RNA polymerase (RdRP). As the 
PV genome is of positive-polarity, 3Dpol must first generate a negative-sense RNA 
intermediate that serves as a template for the generation of multiple positive-sense 
genomic RNA strands. In vivo, the complementary positive and negative- strands of RNA 
are mostly single-stranded, suggesting that the complementary strands are melted by 
either a host or viral protein (132). In order to synthesize positive-sense RNA from the 
newly made negative-sense RNA, the complementary segments must be unwound and 
displaced during or prior to replication.  In vitro, PV 3Dpol has been shown to be capable 
of unwinding long stretches of dsRNA, (~1000 nts), independent of a distinct helicase 
domain and in the absence of other viral or host proteins (35); thus, it is believed that 
3Dpol is able to unwind large segments of dsRNA on its own. Also, the crystal structure 
of the PV 3Dpol elongation complex (EC) indicates that strand separation can take place 
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as the dsRNA enters the polymerase, where a conserved cleft between the index and 
pinky fingers allows the template strand to enter the active site and the non-template 
strand continues across the fingers domain (Fig. 5.1) (60). 
 In Chapters 3 and 4, I showed that the wild-type PV 3Dpol was able to efficiently 
replicate through the  5’ NTR,  a segment of RNA with extensive structure, and that 
mutations to residue 5 of the PV 3Dpol significantly effected this efficiency (71). 
However, when the 5’ NTR was removed polymerase processivity increased for wild-
type polymerase and especially for residue 5 mutants, indicating that distant downstream 
RNA structures have significant effects on 3Dpol processivity and EC stability. When 
looking at the PV 3Dpol-RNA EC structure it is possible that the template or downstream 
duplex could come in direct contact with residue 5 and these contacts could be required 
for EC stability or strand separation (Fig. 5.1A) (60). RNA structures can induce more 
downstream secondary or tertiary structures by folding back upon itself to have RNA-
RNA interaction, as has been seen with the Flavivirus genome (Fig. 5.1B) (4), a family of 
RNA viruses similar to the Picornavirus family of viruses. 
 Here I report the effects of immediate downstream duplex RNA on polymerase 
EC formation and stability, as well as test the stabilities of ECs after formation with 1, 4 
or 7 nucleotide long lock sequences. For these assays we will use the nomenclature EC+1, 
EC+4 or EC+7 to represent EC formation with 1, 4 or 7 nucleotides, respectively.  I also 
investigate the interaction of downstream RNA with the 3Dpol ssRNA templates that 
contain 2-aminopurine (2AP), a fluorescent nucleotide analogue that is sensitive to 
stacking interactions with either adjacent bases or aromatic amino acids (141). Thus, 
when 2AP is incorporated into a nucleotide oligo its fluorescence can be used to report on 
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FIG. 5.1. Possible PV RNA interactions. (A) PV 3Dpol elongation complex. back 
view showing Trp 5 in relation to the downstream dsRNA, the RNA template is in 
cyan and the non-template is in magenta. The polymerase thumb domain is in 
blue, palm domain, grey, and fingers domain is in green, orange, yellow and pink. 
(B) Atomic force microscopy showing circularization of Flavivirus genome 
through RNA-RNA contacts at the 5’ and 3’ NTRs (or UTRs meaning un-
translated region).  5’ssRegion is single-stranded RNA that has a significant 






specific base conformations (42, 43).  When RNA templates containing 2AP are 
replicated, the fluorescence signal can be used as a real time kinetic reporter, indicating 
various RNA conformations during elongation (149). Given this kinetic data we could 
then potentially fit the data using modeling software, to an algebraic equation describing 
the amplitude and rate associated with fluorescence changes related to 2AP threading 
through the active site. Once the 2AP fluorescence change was determined for each 
nucleotide binding site as it enters and exits the polymerase active site, we could then 
monitor fluorescence changes, based on the kinetic fit, that are not associated with the 
amplitudes related to active site. For example, if downstream nucleotides had stacking 
interaction to residue 5 we would see 2AP fluorescence quenched by the aromatic residue 
at position 5; alternatively if the polymerase interacted with the phosphate backbone the 
2AP would exhibit higher fluorescence intensity. 
 The results show that there are significant stabilizing affects from the presence of 
a downstream RNA duplex and, separately, an EC+4 is more stabilizing than EC+1. Also, 
while kinetic modeling of 2AP data was unsuccessful, using the fluorescence intensities 
alone the data indicated intermittent interactions with downstream ssRNA. However, in 
both cases it remains unclear whether these downstream RNA interactions were affected 
by residue 5 mutations. 
5.2 Results 
5.2.1 Downstream duplex has no effect on elongation complex formation and replication 
 To determine the effects of a downstream RNA duplex on EC formation we 
employed RNA templates called dblPETE 8+4_0+9 and dblPETE 8+4_3+8, both of 
which are 8 base pair hairpin primed RNA templates, with a 4-nucleotide, CUCU, lock 
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sequence (EC+4) and a downstream duplex (Fig. 2.3B). The dblPETE 8+4_0+9 has a 9 bp 
downstream duplex in which the 5’ end is base paired with nucleotide 8 in the RNA 
template. Based on the PV 3Dpol-RNA co-crystal structure, this should result in the 5’ end 
just coming in contact with 3Dpol after EC formation but not undergoing any strand 
separation. The dblPETE 8+4_3+8 has a 8 bp downstream duplex with a 3-base fray at 
the 5’ end, and thus the 3 unpaired bases of this template can contact the polymerase  
remote to the template entry site.  PETE 8+4_3_3 RNA template was used as a control 
RNA that has the same sequence and EC+4 lock but no downstream duplex. EC were 
formed and the formation rates were determined by PAGE analysis of the quenched 
samples followed by band quantitation of the IRdye labeled RNAs to determine relative 
amounts of RNA formed, as previously described in Chapter 3.  The EC+4 formation rates 
were determined for wild-type and residue 5 mutations W5A and W5Y as described in 
Chapter 2, Section 2.5.2. All polymerases exhibited single exponential kinetic rates that 
were consistently ~1.5 fold faster than the EC+1 and EC+2 formation rates described in 
Chapter 3 and exhibited the same trend seen for residue 5 mutations where large aromatic 
residue (wild-type and W5Y) were slightly faster at EC formation than smaller residue 
W5A (Fig. 5.2 and Table 5.1). 
  After EC+4 formation rates were determined, we wanted to verify the efficiency 
of wild-type and residue 5 mutants (W5A, W5L and W5Y) 3Dpol replication through 
downstream RNA duplex. This was determined by first forming the stable EC+4 then 
diluting the reaction 20-fold into a high NaCl buffer to prevent reinitiation in the presence 
of 20 µM each GTP, ATP UTP and CTP. Small aliquots of the reaction were quenched at 
0.5, 1, 1.5, 2, and 2.5 minutes and analyzed by PAGE (Fig. 5.3). Results show that     
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FIG 5.2. Elongation complex formation kinetics. (A) Wild-type, (B) W5Y, and 
C) W5A EC formation for dblPETE 8+4_0+9 (blue), dblPETE 8+4_3+8 (red) and 
PETE 8+4_3_3 (green). Data was fit to a single exponential with a significant 
initial offset because the 0 min time point was not subtracted from the data, 
specifically because some the formation is able to take place on ice during 






























































































EC+n Wild-type W5Y W5A 
8+4_0+9 4 1.4 ± 0.2 2.7 ± 0.2 4.3 ± 0.1 
8+4_3+8_3 4 1.02 ± 0.07 2.4 ± 0.1 4.2 ± 0.1 
8+4_3_3 4 0.59 ± 0.01 3.2 ± 0.1 5.2 ± 0.1 
9+2_24 2 3.0 ± 0.2 4.5 ± 0.5 7.5 ± 0.5 
10+1_12 1 2.0 ± 0.1 4.2 ± 0.5 6.6 ± 0.7 
EC+4 formation rates (minutes) 
Table 5.1. Elongation complex (EC) formation on PETE 
RNA templates with downstream duplex. 
 errors based on curve fits of the data 
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FIG 5.3. Elongation of through duplex RNA. (A) Cartoon representation of 
dblPETE 8+4_0+9 RNA used in this experiment. (B) Denaturing PAGE showing 
efficient replication of dblPETE 8+4_0+9 RNA by wild-type, W5A, W5L and 
W5Y 3Dpol mutants. EC+4s were formed, as previously described where S 
represents the starting material and +4 represents the formation of EC+4, for 15 
minutes then chased with 40 µM NTPs and quench by 10 mM EDTA  at indicated 
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wild-type and all residue 5 mutants replicated through duplex RNA at essentially the 
same rate, taking between 1.5 and 2 minutes to replicate through 25 nucleotides.  
5.2.2 Downstream duplex has stabilizing effects on the elongation complex  
 To determine the effects of downstream RNA duplex on EC stability, we 
performed stability experiments as previously described in Chapter 2, Section 2.7, on 
dblPETE 8+4_0+9, 8+4_3+8_3 and PETE 8+4_3_3 RNA templates. EC+4s were 
incubated at room temperature for 15 minutes before being diluted 10-fold into a high 
[NaCl] buffer. Diluted reactions were incubated from 0-300  minutes for wild-type, 0-240 
minutes for W5Y and W5F, and 0-120 minutes for W5A (time points were dictated by 
the previously reported EC decay constants (71)). Reactions were analyzed by PAGE and 
bands were quantitated to determine EC+4 stability by comparing the relative amounts of 
+4 and fully elongated products (Fig. 5.4). The results show that a downstream duplex 
significantly increases the stability of the EC for W5Y and W5F polymerases (Fig. 5.5 
and Table 5.2). EC stability of wild-type was difficult to determine since all complexes 
were very stable, past 300 minutes. Downstream duplex seems to have a smaller effect on 
the W5A polymerase, where the PETE 8+4_3_3 RNA was only 2.1-fold less stable than 
the dblPETE 8+4_0+9 RNA, rather than the 5.4 and 9.1-fold seen with the W5Y and 
W5F mutants, respectively. Also, there is significant increase in EC stability for the W5A 
mutant when using ssRNA PETE 8+4_3_3 compared to the ssRNA PETE 9+2_24 RNA 
that was previously reported (Table 5.2).  
5.2.3 Nucleotide lock length on elongation complex stability: +4>+1>+7 
 To compare the effects of the number of nucleotides added in EC formation on 
EC stability, we performed stability assays, described in Chapter 2, Section 2.7, on ECs 
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FIG 5.4. EC+4 stability.  PAGE analysis of W5F EC+4 stability  on (A) 
dblPETE 8+4_0+9, (B) dblPETE 8+4_3+8 and (C) PETE 8+4_3_3 RNA. 
EC+4 were formed as previously described for 15 minutes then chased by 



















FIG 5.5. EC+4 stability kinetics. Plot of data obtained from PAGE analysis 
showing single exponential loss of 3Dpol EC+4 stability. Data indicate that 
downstream duplex aids in EC stability. Data represents the best data set from 



































































































































wild-type W5Y W5F W5A 
8+4_0+9 2100 ±400 271 ±17 242 ± 12 45.1 ±2.4 
8+4_3+8 1110 ±130 210 ± 10 154 ± 6 32.2 ±1.2 
8+4_3_3 1250 ± 70 50.1 ± 1.9* 25.5 ± 1.6* 21.9 ±1.0 
9+2_24 186 ± 4 56.0 ±3.0 26.0 ± 1.0 5.3 ±0.2 
A. EC+4 stability decay constant (minutes) 
Table 5.2. EC stability on PETE and dblPETE RNA templates. 
RNA 
template 
wild-type W5Y W5F W5A 
8+4_0+9 1.0 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
8+4_3+8 1.8 ± 0.4 1.3 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 
8+4_3_3 1.6 ± 0.3 5.4 ± 0.4** 9.1 ± 0.7** 2.1 ± 0.1** 
9+2_24 11 ± 1.9** 4.8 ± 0.4** 9.3 ± 0.6** 8.5 ± 0.6** 
RNA 
template 
wild-type W5Y W5F W5A 
8+4_0+9 1.0 ± 0.2 7.6 ± 1.4** 9.1 ± 1.6** 45 ± 8.1** 
8+4_3+8 1.0 ± 0.2 5.4 ± 0.6** 7.2 ± 0.9** 35 ± 4.1** 
8+4_3_3 1.0 ± 0.1 24 ± 9** 49 ± 4.1** 57 ± 4.1** 
9+2_24 1.0 ± 0.03 3.3 ± 0.2** 7.1 ± 0.3** 35 ± 1.5** 
B. EC+4 stability fold decrease normalized to wild-type  
C. EC+4 stability  fold decrease normalized to 8+4_0+9 EC complex  
* values required an offset because they did not reach 0% elongation 
** values that differed significantly from the normalized value 
Fold errors were propagated by  (∆𝐴/𝐴)2+(Δ𝐵/𝐵)2= (∆𝑍/𝑍)2 
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that were formed with either +1, +4 or +7 nucleotides on dblPETE 8+4_0+9, 8+4_3+8 
and PETE 8+4_3_3 RNA templates, resulting in the final states shown in Figure 5.6. The 
results of this experiment showed that for most polymerase-RNA complexes, an EC+4 
was more stable than EC+1 and EC+7 (Fig. 5.7 and Table 5.3). Figure 5.7 shows an 
example of W5Y stability data, notice that the EC+7 on the 0+9 template produces a curve 
with a very small amplitude and low starting value, indicative of a polymerase more 
unstable than the curve fit reports.  The 0+9 template EC+7 gel (Fig. 5.7A) shows that 
after 15 minutes of pre-incubation most of the RNA is elongated by 7 nucleotides but the 
chases are very inefficient. The most severe stability effects are from the EC+7 on the 
PETE 8+4_3_3 RNA, where there are only three template nucleotides left after the EC 
formation.  
5.2.4 There is a detectable 2-aminopurine florescence change associated with elongation 
complex formation 
 Since 3Dpol appears to interact with downstream RNA, we designed a 
fluorescence based assay that would allow us to more precisely determine where along 
the downstream RNA template the polymerase-RNA interaction was occurring. We 
designed a set of PETE RNAs that contained 2-aminopurine (2AP) at downstream 
positions +3, +5, +7 and +9 after EC+4 formation (Fig. 5.8). 2AP is an adenine base 
analog with strong fluorescence signal that is extremely sensitive to stacking interactions, 
where the signal is strongest when 2AP is completely un-stacked and is weak when 
quenched by stacking. The RNAs were named using a 9+4apN_13, where 9 is the number 
of base pairs in the self-priming hairpin, +4 is the number of nucleotides adding during 
EC formation, apN is the position of the 2AP (3, 5, 7, or 9) after EC+4 formation and _13 
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FIG 5.6. Cartoon models of expected EC+1,+4 and+7 formations. (A) EC+1 (B) 
EC+4 and (C) EC+7 for dblPETE 8+4_0+9 (top), dblPETE 8+4_3+8 (middle) and 









FIG 5.7. Kinetics of EC+1,+4 and+7 stability. .(A) PAGE analysis of W5Y EC+7 
stability  on  dblPETE 8+4_0+9. Plotted data from PAGE analysis of EC+1 
(blue), EC+4 (red) and EC+7 (green) from W5Y on (B) dlbPETE 8+4_0+9, (C) 
dblPETE 8+4_3+8, and (D) PETE 8+4_3_3 RNA templates. Decay constants are 
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wild-type W5Y W5F W5A 
+1 276 ± 33* 125 ± 4.5 51.4 ± 4.9 18.6± 2.2 
8+4_0+9 +4 2039 ± 555 534 ± 51 226 ± 13 49.3 ± 3.0 
+7 248 ± 33* 301 ± 22* 24.9 ± 3.6* 1.0 ± 0.1* 
+1 360 ± 157 130 ± 11  44.4± 5.1 16.4 ± 1.2 
8+4_3+8 +4 1082 ± 124 271 ± 12** 107 ± 6.9 30 ± 3.0 
+7 529 ± 49 37 ± 1.8 16.3 ± 2.0 11  ± 3.1 
+1 299 ± 22** 75 ± 4.2 40.0 ± 2.0 9.9 ± 0.6 
8+4_3_3 +4 532 ± 27** 154 ± 6.9 82.8 ± 4.8 22 ±0.9 
+7 4.4 ± 0.4 3.8 ± 0.3 3.4 ± 0.5 5.0 ±1.5 
A. EC+1,+4,+7 stability (minutes) 





wild-type W5Y W5F W5A 
+1 7.4 ± 2.3 4.2 ± 0.4 4.4 ± 0.5 2.6 ± 0.3 
8+4_0+9 +4 1.0 ± 0.4 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
+7 8.2 ± 2.5* 1.8 ± 0.2* 9.1 ± 1.4* 48 ± 0.4* 
+1 3.0 ± 1.4 2.1 ± 0.2 2.4 ± 0.3 1.8 ± 0.2 
8+4_3+8 +4 1.0 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
+7 2.1 ± 0.3 7.3 ± 0.5 6.6 ± 0.9 2.7 ± 0.8 
+1 1.8 ± 0.2 2.1 ± 0.1 5.1 ± 0.7 2.2 ± 0.2 
8+4_3_3 +4 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
+7 121 ± 13 41 ± 4 24 ± 4 4.4 ± 1.3 
B. EC+1,+4,+7 stability fold decrease normalized to EC+4  
* stability not accurate: amplitude <0.3% and when x = 0 is y = <10%) 
** values required an offset 
Fold errors were propagated by  (∆𝐴/𝐴)2+(Δ𝐵/𝐵)2= (∆𝑍/𝑍)2 
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Fig. 5.8. UNAfold predicted RNA secondary structure of 2AP templates before 
EC formation. Using the older mfold program predicted only a single 9-base pair 
hairpin ΔG = -24 kcal/mol such as those modeled in Fig. 2.3. After the software 
update  to UNAfold a second 3-base pair hairpin ΔG = -5 kcal/mol was predicted at 













































is the number of total nucleotides in the single stranded template after EC+4 formation. 
See Figure 5.9 for EC formation model. 
 It has been shown biochemically that 3Dpol has two conformational changes upon 
formation of the stable EC (9). This conformational change may have some effect on how 
the polymerase contacts the downstream RNA template. To determine if there is a change 
in downstream RNA interactions during EC formation we utilized 2AP RNA templates in 
a stopped-flow format to monitor 2AP fluorescence, described in Chapter 2, Section 
2.5.3. The four PETE templates, ap3, ap5, ap7 and ap9, used in this experiment indicate 
the final position of 2AP after a EC+4 lock, rather than the starting position. Mixing the 
preformed 3Dpol-RNA complexes with a mock NTP mix containing no NTPs showed a 
slight single exponential increase in fluorescence with an average time constant of 9.5 
seconds for all the RNA templates (Fig. 5.10), which may be related to koff, or k-1 
illustrated in Figure 5.9.  For wild-type 3Dpol formation, the baseline signal when no 
nucleotides were added exhibited single exponential behavior with a time constant of ~9 
seconds with the exception of ap5 which fit the sum of two exponentials and had a slow 
second exponential of 192 seconds, values reported in Table 5.4.  
  In the presence of 40 µM NTPs, EC+4 formation on ap3, ap5, ap7 and ap9 
templates also resulted in an exponential increase in fluorescence signal. ap3 and ap5 fit 
the sum of two exponentials with fast time constants for the first exponential followed by 
slower second exponential. ap7 and ap9 fit a single exponential with time constants 6.0 
and 4.8 seconds, respectively (Table 5.4). The fluorescence traces from ap3 and ap9 
templates started at the same intensity as the 0 µM NTP control but increased 





































FIG. 5.9. Model of  EC formation on 2AP templates. EC formation is broken 
down into four states requiring three steps, as previously reported. States 1 and 2 
polymerase-RNA binding. Upon NTP addition there is a conformational change, 
state 3, (E*) before incorporation of the first NTP. Blue letter represents incoming 
NTP. State 4 shows hypothesized downstream RNA rearrangement associated with 
the E* conformational change and incorporation of the first NTP. After the stable 






































FIG 5.10. 2AP fluorescence during wild-type EC+4 formation. Graphs show 
wild-type 3Dpol-RNA + (purple) or – (black) NTPs. Data was collected by injecting 
equal volumes of +/- NTP solution and preformed 3Dpol-RNA complex via rapid 
stopped flow. Reactions were monitored for 300 s (left). Early exponential 
characteristics can be seen in the first 50 s (right). Data were fit to a single or sum 
of two exponentials. Exponents and their amplitudes are recorded in Table 5.4. 




























































































































































































































































































Table 5.4. 2AP wild-type  EC+4 formation kinetics 
a dissociation modeled in Fig. 5.14. n.a. not applicable  
RNA curve 1st exp 
(sec) 




ap3 single  9.8 0.10 n.a. n.a. 
ap5 double 10.2 0.12 192 0.13 
ap7 single   9.0 0.17 n.a. n.a. 
ap9 single  9.3 0.15 n.a. n.a. 




ap3 double  3.8 0.25 30.5 0.06 
ap5 double 12.6 0.53 52.1 0.09 
ap7 single   6.0 0.15 n.a. n.a. 
ap9 single  4.8 0.56 n.a. n.a. 















than the 0 µM NTP control. The ap5 RNA fluorescence signal started below baseline 
with a lag of ~1 second followed by an exponential increase that has an early time 
constant of 12.6 seconds. The ap7 template exhibited no change in overall amplitude and 
trace characteristics compared to the 0 µM control, but had a small difference time 
constant (Table 5.4). No fluorescence changes were seen when the polymerase was 
omitted from the assay in either the absence or presence of NTPs.   
 When this experiment was repeated with 3Dpol W5L there was only insignificant 
changes from baseline for all of the 2AP RNA templates (Fig. 5.11). All data fit to the 
sum of two exponentials but this is more likely due to data inconsistency and scatter than 
with some specific trend as seen for wild-type. The fluorescence change associated with 0 
µM, indicating k-1, was between scattered between 7 and 16 seconds for each RNA 
template and 8 to 12 seconds for EC+4 formation (Table 5.5).   
5.2.5 There is a detectable fluorescence change associated with 2-aminopurine treading 
through the active site of 3Dpol 
 Using rapid stopped-flow, I monitored the change in 2AP fluorescence during 
elongation of PETE RNA. Experiments were completed similarly to the stopped-flow 
elongation rate experiments in Chapter 3 where EC+4s were preformed, diluted 10-fold, 
and then mixed via rapid stopped-flow with various NTP concentrations. Upon the 
addition of NTPs, all data traces showed a signal increase as 2AP becomes un-stacked 
moving, giving off its maximal fluorescence signal, followed by a decrease as 2AP 
becomes completely base stacked and base paired giving off its minimal signal (Fig. 
5.12). When comparing the data traces from each RNA template, the ap3 data trace 
showed an immediate increase, suggesting that at the +2 position 2AP mostly or 
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FIG 5.11. 2AP fluorescence during W5L EC+4 formation. Graphs show W5L 
3Dpol-RNA + (purple) or – (black) NTPs Data was collected by injecting equal 
volumes of +/- NTP solution and preformed 3Dpol-RNA complex via rapid 
stopped flow. Reactions were monitored for 200 s (left). Early characteristics can 







































































































































































Table 5.5  2AP W5L EC+4 formation kinetics 
a dissociation modeled in Fig. 5.14 








ap3 double  7.1 0.06 48.9 0.16 
ap5 double  11.3 0.19 243 0.31 
ap7 double   11.8 0.12 100 0.11 
ap9 double  16.6 0.06 137 0.14 








ap3 double  12.1 0.05 89.6 0.10 
ap5 double  12.9 0.15 278 0.35 
ap7 double  5.7 0.13 58.7 0.11 
ap9 double  8.7 0.17 110.6 0.16 
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FIG 5.12. 2AP fluorescence associated with 3Dpol elongation. (A) Fluorescence 
signal from each 2AP RNA template (Fig 2.3) by wild-type 3Dpol. Elongation was 
initiated by the addition 5 µM NTPs to preformed EC+4s in rapid stopped-flow 
format. Elongation was monitored for 200 seconds. Inset shows first 15 seconds 
for comparison of peak fluorescence intensities: ap3, ~0.7 s; ap5, ~1.7 s; ap7, ~3.1 
s; ap9, ~8.2 s, for an overall rate of ~1.5 nts/second (B) Crystal structure of PV 
3Dpol EC showing the single stranded RNA template threading through the active 
site. +3 (cyan), +2 (purple), and +1 (orange) nucleotides are shown in thick stick 






















completely un-stacked. ap5, ap7 and ap9 traces show a lag phase indicative of time for 
the 2AP to reach the +2 position (Fig. 5.12A). The replication rate on each template can 
be calculated by dividing the 2AP-2 starting position by the time it takes to reach 
maximum fluorescence, resulting in an elongation rate of ~1.5 nt/sec (Fig. 5.12A inset). 
The peak intensities broaden for templates where the 2AP starting position is further from 
the active site, indicating a larger distribution of states in the elongating population. A 
direct comparison between wild-type and W5Y mutant shows that there is very little 
difference between elongations of any of the templates with the exception of ap7 which 
has a smaller amplitude for the increase compared to the other RNA templates (Fig. 
5.13).  
 Data traces of an NTP series on the ap9 template with wild-type, W5Y and W5L 
were subtracted by the terminal value and show that the lag phase shortens as NTP 
concentrations increase until a Vmax is reached between 80 and 120 µM NTPs. Overall, 
the signal to noise was significantly lower for W5Y and W5L mutants, due to EC 
instability (Fig. 5.14). With these data and data shown in Fig. 5.12 I attempted to design a 
mathematical equation that could model the data based on discrete fluorescence 
intensities for each downstream NTP position. However, kinetic modeling of data traces 
was unsuccessful due to difficulty in associating each nucleotide position with the 
relative to the active site +3  +2  +1  -1 with a specific amplitude, or vice versa. 
Because I could not model an absolute value for elongation through the active site, it was 
impossible to mathematically elucidate mutation-induced changes in signal due to 
interactions outside the active site, so data can only be analyzed by visually. 
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FIG. 5.13. Comparison of normalized 2AP signals during elongation. Graphs 
show 2AP template by wild-type (black) and W5Y (orange) in the presence of 15 
µM NTPs. Data was collected by injecting equal volumes of +/- NTP solution 
and preformed EC+4 via rapid stopped-flow. Reactions were monitored for 100 s 
(left). Early 2AP characteristics can be seen in the first 10 s (right) and show 














































































































































































FIG 5.14. NTP series on ap9 template by wild-type and residue 5 mutnats. EC+4 
were formed as previously described for 15 minutes, diluted 10-fold for sample 
loading then 2 fold upon injection with NTPs. Data collected by rapid stopped-flow 
for 80-200 s (right) and show elongation of ap9 RNA templates by (A) wild-type, 
(B) W5Y and (C)W5L. Date demonstrate expected increase and decrease for 
elongation by all polymerases but peak intensities are difficult to discern for the 
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 In vivo, picornavirus genome replication requires a processive RNA-dependent 
RNA polymerase (RdRP) that is able to replicate through extensive RNA structures (89). 
Currently, the structural aspects that enable the polymerase to replicate through extensive 
RNA structure are unknown. Some reports speculate viral protein 2C may act as a 
helicase to aid in dsRNA unwinding (135, 136) while other reports show that 3Dpol is 
able to unwind large segments of dsRNA single-handedly (35). In Chapters 3 and 4 we 
illustrated that mutations at PV 3Dpol residue 5 have significant effects on elongation 
complex (EC) stability and replication processivity. In this work, we have investigated 
the modulation of EC stability by interactions of the PV 3Dpol with downstream RNA and 
the number of nucleotides incorporated during EC lock formation. We saw in Chapter 4 
that downstream 5’ NTR, an element of extensive RNA structures, had significant effects 
on polymerase processivity. Also, the PV 3Dpol-RNA co-crystal structure shows that 
residue 5 is in a position that could potentially interact with the RNA template or 
downstream duplex (Fig. 5.1) (60).  
 To determine the effects of downstream duplex on EC formation, replication rate 
and EC stability, we utilized double hairpin RNA templates where one hairpin provided 
the 3’OH primer and the other hairpin provided a downstream duplex to simulate RNA 
structures (Fig. 2.3).  The EC+4 formation assays showed that downstream duplex had 
very little effect on EC formation (Table 5.1). When stable ECs were chased, after 15 
minutes of formation, wild-type and residue 5 mutants were able to efficiently replicate 
through the duplex at similar rates, about 15 nts/min (Fig. 5.3). These rates were slightly 
slower than the replication rates through a ssRNA template that was analyzed by PAGE 
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in similar conditions, likely due to high NaCl concentrations favoring RNA structure 
requiring more energy to replicate through duplex.  
 In Chapter 4, I found that replication of the PV genome was severely impaired for 
residue 5 mutants by the presence of multiple abortive products during RNA replication 
in high salt. I hypothesized that this was due to extensive RNA structure and showed that 
when we remove the 5’ NTR including the IRES (an element of highly structured RNA,) 
replication through the genome was much more efficient, while EC stability was not 
changed. Stability assays performed on smaller RNA templates with downstream duplex 
RNA showed that the presence of a downstream duplex significantly enhanced the 
stability for W5Yand W5F but not for wild-type and W5A (Fig. 5.5 and Table 5.2). 
However, the wild-type stability was difficult to determine because the polymerase was 
so stable after a +4 lock that only very small amplitudes were curve fit (Fig 5.5). As 
history has shown, it is most likely that the wild-type polymerase would behave like the 
W5Y and W5F polymerases when taken out to longer time points. The fact that the W5A 
mutant was not significantly affected by the presence of a downstream duplex suggests 
that residue 5 has stability effects on 3Dpol interactions with the downstream RNA or 
downstream duplex.  Also interesting was the significant increase in W5A EC+4 stability 
when comparing the single-stranded control RNA used in this experiment to the ssRNA 
template (PETE 9+2_24) that was used previously (Chapter 3) to determine EC+2 
stability. This result indicates that EC+4 is more stabilizing that EC+2, which can 
somewhat overcome the devastating effects a residue 5 mutation has on polymerase 
stability.     
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 To more directly compare how the number of nucleotides incorporated upon EC 
formation affected stability, we used the dblPETE RNA templates (8+4_3+8_3 and 
8+4_0+9) and the ssRNA PETE control (8+4_3_3) to vary the nucleotides incorporated 
by +1, +4, or +7 depending on a pre-incubation with ATP, ATP and GTP, or ATP, GTP 
and UTP, respectively. These experiments showed that for all 3Dpol-ECs the EC+4 was 2-
3 fold more stable than the EC+1 and 2-120 fold more stable than the EC+7 (Fig. 5.7 and 
Table 5.3). The most unstable complexes for all polymerases were generated by EC+7 on 
the ssRNA control, where after the incorporation of 7 nucleotides there are only 3 
template nucleotides remaining. This suggests a requirement for significant downstream 
RNA contacts to maintain a stable complex. This was not surprising as a previous report 
from our lab showed that the PV 3Dpol on a similar ssRNA template, 5’ end labeled with 
a fluorescein, the polymerase came into contact with the fluorescein when the polymerase 
was positioned  5 nucleotides from the end (59). The result that the EC+7 was less stable 
than either EC+4 or EC+1 on the longer dblPETE templates was surprising because the 
downstream contacts should still be intact and able to contribute the stabilizing effects. 
Even if the downstream duplex was no longer intact, we would expect the EC+7 to be at 
least as stable as the EC+4 on the ssRNA control; instead, it was significantly less stable. 
The fact that the EC+7 is much less stable than EC+4 is either due to a conformational 
change in the polymerase or differences in RNA contacts or sequence.  For example, it 
could be that there are conformational changes associated with strand displacement that 
make the polymerase less stable. In support of this is the comparison of EC+7 on dblPETE 
8+4_0+9 and EC+4 on dblPETE 8+4_3+8, which should be nearly identical in 
polymerase-RNA contacts; the only differences are the number of nucleotides 
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incorporated (+4 vs. +7) and the nucleotide composition at the +1, +2 and +3 positions, 
which are shown in the PV 3Dpol EC to interact with the polymerase (60). However, the 
results showed EC+7 was significantly less stable than  EC+4; therefore, either the act of 
displacing 3 RNA bases, during formation of EC+7, or the composition of nucleotides in 
positions +1, +2, and +3 determines EC stability. In this experiment the three single 
stranded template nucleotides threading through the active site are 3’-AAG-5’ for EC+7 
and 3’-GGU-5’ for EC+4. There has been evidence of abortive sequences for other 
polymerases, for example, T7 has an abortive sequence 5’-TATCTGTT-3’ (96). 
However, no such data exists for the PV 3Dpol nor other related RdRPs. Therefore, further 
biochemical studies are needed to determine if sequence specific effects are responsible 
for the EC stability differences. The importance of template nucleotide sequence could be 
tested by repeating stability experiments on RNA designed to look have different 
template sequences after the same lock length.  
 To further investigate 3Dpol-RNA interactions we incorporated 2-aminopurine 
(2AP), a fluorescent adenine analog whose signal can be quenched by stacking 
interactions, into our PETE RNA at various positions (ap3, ap5, ap7 or ap9). Our 
rationale was if downstream nucleotides had a stacking interaction with residue 5, then 
we would see 2AP fluorescence quenched by aromatic residue at position 5; alternatively 
if the polymerase interacted with the phosphate backbone this could result in a more 
solvent exposed 2AP we would see higher fluorescence intensity.  
 It has been shown for both PV and FMDV picornavirus polymerases that EC 
formation is a rate limiting event associated with a conformational change in the 
polymerase resulting in a very stable complex (7, 9). This conformational change could 
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create or change the interaction between 3Dpol and the RNA which could be detected by 
monitoring EC formation with the 2AP RNA templates. Since, EC formation on these 
templates was designed to be the addition of the first four nucleotides, the data traces 
from this experiment show the movement through 4 nucleotides before being stalled. The 
movement, described by the starting and ending position of 2AP for each template is as 
follows: ap3, 73; ap5, 95; ap7, 117; ap9, 139. The secondary structure 
predictions based on the new UNAfold program show that for each of the 2AP RNA 
templates there are two possible hairpins, the designed 9 bp priming hairpin and a second 
3 bp downstream hairpin that is unable to exist after the lock because the bases are 
interacting with the polymerase (Fig. 5.8). Thus, ap3 and ap9 could have a somewhat 
quenched fluorescence signal upon 3Dpol binding, but should increase upon formation of 
EC+4, while ap5 and ap7 templates should have no change in fluorescence unless a 2AP 
interacts with the polymerase.  
 Upon addition of NTPs the results showed the expected fluorescence increase for 
ap3, ap7 and ap9 RNA templates indicating formation of the EC (Fig. 5.10). 
Interestingly, the 2AP fluorescence from the ap5 template was quenched compared to the 
addition of 0 µM, indicating an alternative RNA conformation upon EC formation that 
can be detected by the ap5 template (Fig. 5.15 states 3 and 4). Since it is known that there 
are conformational changes associated with EC formation (9) it is likely that the 2AP at 
position 5 is sampling different environments caused by a conformational change within 
the polymerase upon addition of NTP. Curve fits of the fluorescence data showed that 
ap3 and ap5 exhibited the sum of two exponentials, indicating that there are two events 


































FIG. 5.15. Final model of  EC formation with data adaptations. The EC 
formation model from Fig. 5.9 has been adapted to correlated data from this 
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formation rates while the second rate for ap3 and ap5 are the dissociation rate of the EC+4 
which is ~3-5 fold slower than the dissociation rate of the RNA-3Dpol complex alone, 
which is similar to previous reports (9).  This second exponential was not seen for the ap7 
and ap9 templates most likely because the 2AP is too distant to show these interactions. 
When these experiments were repeated with the W5L mutant there was no significant 
change in 2AP signal compared to the 0 µM NTP control (Fig. 5.11 and Table 5.5). This 
could indicate a loss of interaction between the RNA and residue 5, or residue 5 could be 
providing some structural maintenance of 3Dpol required for RNA interactions elsewhere 
on the polymerase. However, I cannot rule out that this polymerase may just be too 
unstable to monitor formation EC+4 in the stopped-flow format. 
 As 2AP RNA templates are elongated, the predicted fluorescent traces of 2AP 
movement through the active site were seen, based on the PV EC crystal structure 
showing +3, +2 and +1 nucleotides in a stacked, un-stacked, stacked orientation, 
respectively (Fig. 5.12) (60). I attempted to fit these data traces, particularly ap3 since the 
interactions of the nucleotide at position 3 are known (60), to a kinetic equation that 
reported on 2AP threading through the active site. The reason being that if I could 
determine the amplitude and kinetics of 2AP at positions +3, +2, +1 and -1 then I could 
monitor changes in data traces that were independent of the active site fluorescence 
changes. Specifically, I expected to see early, unpredicted, fluorescence changes that 
suggested 3Dpol-RNA interactions beyond the active site and that these may be changed 
by the W5 mutations, indicating this residue was contributing to downstream RNA 
contacts. The traces from elongation by the wild-type polymerase on all four RNA 
templates (ap3, ap5, ap7 and ap9) showed the predicted fluorescence increase and 
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decrease as the template RNA moved through the 3Dpol active site. Replication rates, 
determined by the time to reach maximum fluorescence (2AP to reach position +2),  was 
similar for each RNA template (Figure 5.12A). However, although the data were clean 
and repeatable, the kinetic modeling proved to be problematic in that a set of successive 
amplitude could not be fit to any two data traces. This was likely due to the fact that there 
are multiple intermediate RNA-polymerase interactions (see Fig. 5.15 step 3 for model). 
Since 2AP is very sensitive to environmental changes, we can only properly fit obvious 
changes from the data traces, making it difficult to model the more comprehensive 
analysis we had hoped for. 
 Comparing the data traces of wild-type and W5Y from the four RNA templates, 
we found very little evidence of alternative interactions between the two polymerases 
(Fig. 5.13). However, for both polymerases the ap7 template seems to have smaller 
amplitude associated with the increase. This could indicate that when 3Dpol is stalled on 
the ap7 template after EC+4 formation, the nucleotide at the +7 position has fewer 
stacking interactions than when at the +3, +5 or +9 positions. Alternatively this could be 
a characteristic of this particular RNA construct. To determine such interactions more 
RNA templates would need to be synthesized with 2AP at alternative positions and 
examined for elongation. 
 To elucidate whether fluorescence changes were dependent upon residue 5, I 
monitored elongation of ap9 with various NTP concentrations for wild-type, W5Y and 
W5L 3Dpol enzymes. The 2AP fluorescence data in Figure 5.14 show that the signal to 
noise was too low to determine the peak signal intensity for most of the W5L data traces, 
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making it difficult to elucidate any differences in early interactions. Thus, it remains 
unclear whether interactions with wild-type and W5Y would be affected by residue 5.   
 In conclusion, these data show that 3Dpol EC stability can be modulated by 
downstream RNA interactions and EC lock length. Some of these interactions are 
stabilizing, as seen by with the downstream duplex, and some are destabilizing, such as 
the interaction when the dblPETE template EC+7. I have also shown some evidence for 
structural rearrangement of RNA during EC formation via RNA-3Dpol interactions on 
2AP RNA templates. In any case, it is not exactly clear whether downstream RNA 
interactions or rearrangements are directly with or affected by residue 5 or with some 
other area on the polymerase. In all, these are the first reported data that indicate 3Dpol 
interactions exist with the downstream RNA template beyond the polymerase active site. 






Discussion and Future Directions 
6.1 Introduction 
 RNA viruses are responsible for many acute and chronic diseases in humans, 
plants and animals. The enzyme responsible for replication of viral RNA genomes is the 
RNA-dependent RNA polymerase. Due to its uniqueness to the virus and requirement for 
viral multiplication, the RdRP is considered an ideal enzyme for a drug target and has 
therefore, been the subject of much antiviral research. As novel RNA viruses are 
continually emerging (128) and more information is being discovered about the RdRP, 
the poliovirus (PV) RdRP has proven to be an important model enzyme for elucidating 
structure-function relationships in all RNA virus RdRPs.   
 Results presented in Chapters 3-5 have advanced the field in the area of structure-
function relationships of the picornavirus RdRP. Experiments have demonstrated that 
residue 5 of the poliovirus (PV) RdRP is required for elongation complex (EC) stability 
and processive elongation of the PV RNA genome. Furthermore, I showed evidence of 
PV polymerase interactions with downstream RNA and show that EC lock length and 
downstream duplex also a role in EC stability. In this chapter I will discuss how these 
findings have filled in some gaps within the field and touch on some future directions that 
will be important for further elucidation of structure-function relationships of 3Dpol. 
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6.2 The Picornavirus Replication Complex Stability and Processivity 
 In the host cell, PV replication is extremely robust, reaching upwards of 5.0x105 
copies of the positive-strand genome within six hours post infection (112). This level of 
replication requires that the polymerase be highly active and processive. In 2000 Arnold 
and Cameron described the assembly of the PV 3Dpol stable elongation-competent 
complex as the enzyme-RNA-1st NTP complex (9). The incorporation of the first 
nucleotide is a rate-limiting step in replication that results in a complex that is >4 fold 
more stable than the enzyme-RNA complex before nucleotide incorporation. This step of 
initiation is required for processive elongation (9). However, to date there has been very 
little data collected on the processivity of the PV 3Dpol. In 2001, Rodriguez-Wells et al 
(134) described a study where the processivity of PV 3Dpol was directly measured via 
primer extension. The authors reported that the 3Dpol was a highly processive polymerase 
based on the observation that the primer extended to a final product of 1388 nucleotides 
(134). However, the resolution obtained from the denaturing PAGE where the replication 
products were analyzed was <800 nucleotides, so abortive products between ~700-1388 
nucleotides could not be resolved (Fig. 6.1). This is not to say that the PV polymerase is 
not processive, but it could be that the polymerase only replicates about 1000 nucleotides 
on average before dissociation rather than the one initiation event per genome replication 
proposed by the authors of this study.  An earlier report, that investigated the unwinding 
capabilities of PV 3Dpol, indirectly reported on the processivity of the polymerase using a 
method similar to 3’ self-priming method I used in Chapter 4 (35). In that study the 
authors transcribed a long (nucleotides 4600-7500 of the positive-strand genome) RNA 
template from PV cDNA using T7 RNA polymerase and showed that when the template 
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FIG. 6.1. Analysis of primer extension by wild-type PV 3Dpol.  
PAGE of primer extension used to show that PV 3Dpol is a processive polymerase.  
Reactions were performed by incubation of 13 nM 3Dpol, 5 nM template/primer, 50 
µM NTPs for 1 hour at 30oC Reactions used a 1499 nucleotide template and a 20 
nucleotide 5’-32P-labeled RNA primer. Full primer extension results in 1388 
nucleotide product. PV protein 3AB was added in some cases to monitor changes 
in processivity. A heparin trap was added in some cases to prevent reinitiation. 
Reaction products were analyzed by 6% denaturing PAGE. Figure adapted from 
Rodrigues-Wells et al 2001. Nucleic Acids Res. (134) 
Primer extension by wild-type PV 3Dpol 
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alone was incubated with 3Dpol and NTPs a predominant product roughly twice the size 
of the template was made suggesting that the 3’ end of the template was snapping back to 
form a hairpin primer (35). The products of these reactions were very homologous, 
suggesting that the snap-back was very specific, whereas in the similar experiment I 
performed I had two initiation sites, represented by the tow bands shown in Fig. 6.2B. 
However, this can likely be explained by different reaction conditions, where my 
reactions were completed in high NaCl concentrations favoring RNA structures and 
possibly alternative snap-back structure. 
 The significance of my data is that a residue at the N-terminus of the poliovirus 
polymerase is required for processive elongation. I showed that PV residue 5 was 
involved in the stability of the elongation complex and that EC stability had directed 
effects on processivity. My results presented in Chapter 4 showed that the wild-type 3Dpol 
was very processive, having only a few abortive sites during replication of the first 2201 
and 5424 nts of the RNA genome and that residue 5 of the polymerase has significant 
involvement in its processivity. Also, in collaboration with the Barton lab in Denver, we 
showed that the less processive mutants greatly affect the ability of the infectious virus to 
replicate in a cell-based assay. To my knowledge, this is the first report directly 
characterizing a specific residue of the PV 3Dpol involved in processivity based on assays 
complete with sub-genomic RNA templates. Also novel, was the finding that removal of 
the 5’ non-translated region (NTR) of the genome (nucleotides 15-1123), which contains 
areas of extensive RNA structure, increased processivity of the wild-type and residue 5 
3Dpol mutants.   
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FIG. 6.2. Snap-back/self-primed RNA template elongation. (A) Schematic of 
PV sub-genomic RNA used in self-priming elongation experiments, analyzed by 
gels in B and C. 5’ NTR and 3’ poly(A) tailwas removed  and 3’ end forms snap-
back has hairpin structure. (B) Alternative priming from two different snap-back 
structures, adapted from Fig. 4.6, showing that in high NaCl there can be multiple 
priming sites. In this gel there are two bands one (2x) represents the larger product 
that is likely twice the size of the starting material (S). The second band (2x-n) is 
from an alternative priming sight that primes upstream (n) of the 2x band and is 
more abundant in this particular experiment. (C) Agarose gel showing elongation of 
single snap-back priming site. Adapted from Cho et al. 1993. J. Virol. Lanes 1 and 
6 marker, 2 and 3 elongation, and  3 and 4 marker are repeats. 2x is a product twice 
the size of the starting material (S). 2x-n is twice S minus some n number of 
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 In Chapter 5, I investigated the reactions with downstream RNA and found that 
PV 3Dpol does interact with downstream RNA but the extent to which residue 5 is 
involved remains unclear. This is likely due to the fact that downstream interactions are 
transient and thus difficult to discern for polymerases that are non-processive and 
unstable in a stalled complex. These intermittent interactions could be due to a 
conformational change with in the polymerase which changes the orientation of the RNA 
in the entry channel. This is the first evidence for PV RNA-3Dpol interactions outside of 
the RNA binding site (31), but would not be the first report of a conformational change 
for the reorganization of the viral RNA (9, 26). Beckman and Kirkegaard (26) were the 
first to describe a conformational change in the polymerase upon RNA binding, 
determined by changes in IC50s when binding RNA oligos of different lengths. Later 
Arnold and Cameron (9) used AMP incorporation into a primer/template to determine the 
rate of the conformational change to be ~0.08 s-1, similar to the off rate described by my 
2AP EC formation assays of ~0.1 s-1. 
6.3 Future Directions 
6.3.1 Effects of Zn++ on EC stability  
 PV 3Dpol residue 5 has significant effects on viral replication processivity via 
aiding in the stability of the elongation complex. However, the structural details as to 
how residue 5 is affecting polymerase stability are still unknown. The crystal structures 
of the coxsackievirus and poliovirus polymerases show that there is a conserved β-strand 
distortion and large hydrophobic residue at position 5 (32, 152). Adjacent to residue 5 
there is a hydrophobic pocket into which residue 5 could possible rotate in to, burying the 
hydrophobic residue and resolving the β-strand distortion into a β-sheet with the middle 
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finger. However, we have seen no evidence of such structural changes even after the 
solving the structure of a 3Dpol elongation complex (60).  However, also adjacent to this 
β-strand distortion at position 5 is a group of amino acid side chains presented on the 
middle finger that have possible metal binding geometries, specifically to Zn++ (148) 
having two histidine (residues H270 and H272) and a cysteine and possibly glutamine 
(residue 4) (Fig. 6.3). Zn++ binding sites such as these commonly play a role in the 
structural stability of a protein (148).  In this case, mutations to residue 5 of the 
polymerase could change or affect the geometries of the adjacent metal binding site 
affecting the overall structural stability of the polymerase. However, most reports show 
that higher concentrations of Zn++ in the cell inhibit picornavirus replication but it is not 
clear if these increased Zn++ concentrations have any direct effect on the polymerase (82, 
87, 126). More recently Zn++ has been shown to bind, directly to and inhibit the 
Coronavirus RdRP to prevent RNA binding (150), however, these assay did not 
investigate possible effects the RdRP after binding. It could be that Zn++ aids the 
polymerase some structural rigidity that inhibits binding but could be beneficial after 
RNA binding to form a stable elongation complex.    
6.3.2 Abortive elongation “hot-spots” 
 When investigating polymerase processivity in Chapter 4, I pointed out a few 
abortive “hot-spots” during replication of the sub-genomic RNA. It would be interesting 
and novel to investigate the sequence or RNA structure of these “hot-spots”. There are 
currently no reports of RNA sequences that are abortive for any RNA virus polymerases. 
However, there are such sites for the T7 DNA-dependent RNA polymerase (96). As very 
little is known about RdRP processivity it is reasonable to imagine that abortive 
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FIG. 6.3. 3Dpol crystal structure showing  potential Zn++ binding site. (A) 
complete PV 3Dpol structure showing rotated slightly from back view to show 
potential Zn++ binding residues on middle finger (orange). Residues H270, H272 
and C281 are shown as sticks, with nitrogen atoms in blue and sulfur in yellow. (B) 





sequences may exist but are currently undetected. Or these abortive hot-spots could be 
related to areas of significant RNA structure. Such assays could be performed by 
generating cDNA copies of abortive products from gel purified RNA bands that can be 
transformed in to bacteria for plasmid purification. Various bacterial isolates can then 
DNA prepared and cDNA sequences can be obtained (78). These results would show 
exactly where the abortive sites are then it could be determined whether or not these sites 
were sequence dependent or RNA structure dependent. Even though 3Dpol was able to 
elongate though extensive structures somewhat efficiently in my processivity assays, in 
the cell additional viral proteins may be required to relax the RNA for processive 
elongation, such as viral protein 2C, a known ATPase that could have helicase like 
activity (136).  Thus, smaller abortive products may not be observed incellular viral RNA 
isolates.  
6.3.2 Fidelity of residue 5 mutants 
 Substantial amounts of research are currently underway to describe the structure-
function relationships of the picornavirus 3Dpol related to fidelity (14, 109, 122, 162). As 
discussed in Chapter 1, 3Dpol has no exonuclease activity which results in the enzyme 
having relatively low fidelity (33). This is commonly thought to be advantageous to the 
virus as low replication fidelity increases the genetic diversity of the virus population 
promoting mechanisms of virus evolution generating what is known as quasispecies (73, 
153). In 2003, Pfieffer and Kirkegaard found a single point mutation in the PV 3Dpol that 
causes resistance to the antiviral ribavirin via increased enzyme fidelity (G64S) (123). 
G64 is located in the palm domain of the polymerase but is remote to the catalytic active 
site. This mutation seems to have very little structural significance while having large 
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effects on enzyme fidelity (14). It could be that residue 5 has some similar effects in that 
it could affect fidelity while having no structural interaction with the residues involved in 
catalysis; therefore, it may be interesting to investigate the polymerase fidelity of various 
residue 5 mutants. It is known that misincorporation decreases the rate of incorporation 
for the single nucleotide (81); therefore, any extra time spent in a stalled complex during 
misincorporation increase the chances of dissociation especially by mutants that are 
unstable. In this case, it would be interesting and novel to correlate polymerase 
processivity effects on fidelity. Since I have already generated infectious virus with 
residue 5 mutations, it would be straightforward to perform a comparative fidelity screen 
using the guanidine-resistance assay (39, 123). As previously described, guanidine HCl is 
commonly used to inhibit negative-strand RNA synthesis (21) and this can be overcome 
by single point mutations in viral protein 2C resulting in guanidine resistance (15, 125). 
These experiments are performed by using high titer stocks to infect cells in the presence 
of low molar guanidine, if the fidelity of the polymerase increases fewer point mutations 
will be generate decreasing the frequency of guanidine resistant populations in respect to 
the wild-type frequency (123). Alternatively, if the fidelity is decreased the frequency of 
guanidine resistant populations will increase. If different error frequencies were found it 
might then be interesting to obtain and actual error rate, for which RT PCR and sequence 
of cDNA could be looked at and/or in vitro fidelity could be examined by monitoring 
misincorporation on our fluorescence PETE RNA by the addition of increasing 
concentrations of the incorrect nucleotide. Using the PETE assay higher fidelity mutants 
would require higher concentrations of the incorrect nucleotide to drive misincorporation, 
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where lower fidelity mutants would incorporate the incorrect nucleotide when present at 
low concentrations. 
6.4 Conclusion 
 In all, a more complete understanding of the structure-functional relationships of 
viral polymerases facilitates in the design of specific enzyme inhibitors that could 
eventually serve as antivirals to aid in restriction of virus-caused diseases and their 
transmission; therefore, understanding the differences between these viral and cellular 
enzymes is crucial. The work presented in this dissertation further elucidates structure-
function relationships of the PV 3Dpol, the enzyme required for genome replication. 
Although eradicated in most developed countries, PV is still a medical heath concern in 
less developed countries causing potentially debilitating poliomyelitis; also, PV 3Dpol 
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